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1. Introduction 
 
The purpose of this review is the evaluation of the active ingredient imazapyr when formulated 
for the use as an aquatic herbicide for weed control in lakes and ponds in Massachusetts. The 
regulatory process for registration and approval for use of new aquatic herbicides in 
Massachusetts’ lakes and ponds requires a special review of new aquatic herbicide active 
ingredients.  
 
The initial review of imazapyr was prepared with the objective to provide information for the 
Massachusetts Pesticide Board Subcommittee’s evaluation for registration of the aquatic 
herbicide. Following the registration by the Subcommittee, the new aquatic herbicide active 
ingredient is subject to a review for addition to the Eutrophication and Aquatic Plant 
Management in Massachusetts Final Generic Environmental Impact Report (GEIR) (Mattson et 
al., 2004). The GEIR is intended to provide guidance to lake and pond managers, conservation 
commissions, and citizens concerned with lake management issues. It was also developed to 
provide a basis for a more consistent and effective lake management in the Commonwealth. The 
GEIR describes technical approaches and management options for control of aquatic vegetation 
and for the protection and enhancement of lakes and ponds in Massachusetts. It was written to 
allow for more efficient navigation through the regulatory process and satisfy the requirements 
of the Massachusetts Environmental Policy Act (MEPA). Use of a herbicide that is included in 
the GEIR implicitly confers compliance with MEPA requirements for the application of 
herbicides to aquatic habitats in the Commonwealth (301 CMR 11.00).  
 
The technical guidance in the GEIR includes information on the herbicides that are approved for 
use in lakes and ponds to control aquatic vegetation (Appendix III of GEIR). These herbicide 
profiles include information on chemical and physical properties of the herbicide, its uses and 
application, mode of action, toxicity, and environmental fate. Potential for risks to human health 
and the environment are also addressed and, if applicable, regulatory restrictions that go beyond 
those on the product label may be included.  
In order to have new active ingredients and products added to the GEIR, a critical technical 
review is conducted by staff of MassDEP-ORS and MDAR1. The review is conducted with an 
emphasis on non-target aquatic toxicity. The recommendations may include additional 
restrictions on use of the herbicide. The review presented here is intended to provide the basis for 
the update to the GEIR with the new active ingredient imazapyr. 
 
The general use profile for imazapyr is for control of weeds, brush and undesirable vegetation on 
terrestrial and aquatic sites. Relative to the use in rights-of-way (ROW), it is worthwhile to point 
out that imazapyr is included on the Sensitive Areas Materials List for Rights-of-Way (ROW) 
vegetation management in MA. Herbicide products on this list have gone through a special 
review and approval process that is conducted collaboratively by MDAR and MassDEP for 
herbicide use in sensitive areas in ROW, such as water bodies and inhabited areas. The increased 
level of control is sought for ROW herbicides to ensure that these sensitive areas are sufficiently 
protected from potential risks associated with herbicide use.   
                                                 
1 MassDEP-ORS – Massachusetts Department of Environmental Protection – Office of Research and Standards; 
MDAR – Massachusetts Department of Agricultural  Resources 
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At the time of this review, there were ten products registered in Massachusetts for use on sites 
other than lakes and ponds. The following products were requested for addition to the GEIR, 
such that these products would be allowed for use in lakes and ponds in Massachusetts: 
 
• Habitat ® Herbicide; EPA. Reg. No. 241-426; Application date: 2/12/2004 
• Imazapyr E Pro 2 VM & Aquatic herbicide; (EPA. Reg. No. 81959-8; Application date: 
5/27/2004 
 
These products are very similar in composition, both having the same active ingredient content 
of 28.7% isopropyl amine salt of imazapyr. Habitat® herbicide is labeled for aquatic and wetland 
use only, while Imazapyr E Pro 2 herbicide labeled uses include both terrestrial and aquatic sites. 
At the time of the preparation of this review, Imazapyr E Pro 2 was registered in MA for 
terrestrial use only.   
 
As a result of the reregistration review of imazapyr that was completed by USEPA in 2006, a 
number of review and risk assessment documents were available as information sources for the 
review presented here. Documents and links to e-docket are available at the EPA website:  
Imazapyr | Pesticides | US EPA (www.epa.gov/oppsrrd1/reregistration/imazapyr). The e-docket 
provides access to information, including risk assessments and decision documents related to the 
reregistration review of imazapyr. The special review for aquatic use in MA draws primarily 
from the information available in the e-docket. Additional information was retrieved from the 
various sources, including published scientific studies and government documents. A guide to 
the various information sources that were used with the preparation of this special review is 
included in Appendix 1.  
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2. Chemical Overview  
 
2.1.  Chemical Identity 
 
Imazapyr is part of the imidazolinone chemical class. Imazapyr is a systemic, non-selective, pre- 
and post-emergent herbicide used for the control of a broad range of terrestrial and aquatic 
weeds, and controls plant growth by preventing the synthesis of branched-chain amino acids. 
Imazapyr is applied either as an acid or as the isopropylamine salt (US EPA, 2006).  
 
The nomenclature is summarized in the Table 2.1 below: 
 
Table 2.1. Imazapyr Acid and Salt Nomenclature 
Imazapyr, acid 
Structure 
Molecular Formula C13H15N3O3 
IUPAC Name [2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-nicotinic acid]
CAS Number 81334-34-1 
PC Code 128821 
 
Imazapyr, salt 
 
Molecular Formula C13H15N3O3C3H9N 
IUPAC Name 2-Propanamine, 2-(4,5-dihydro-4-methyl-4-(1-methylethyl)-5-
oxo-1H-imidazol-2-yl]-3-pyridinecarboxylate 
CAS Number 81334-34-1 
PC Code 128821 
Source: RED for Imazapyr (USEPA, 2006) 
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2.2.  Registration and Reregistration History 
 
Imazapyr technical was first registered in 1985; however, a non-crop end use product had been 
previously registered in July 1984. The first food use on corn was registered in April 1997. In 
2003, the aquatic and grassland uses were registered which resulted in the establishment of 
additional tolerances. Currently there are 24 tolerances listed in 40 CFR § 180.500 for residues 
of the herbicide imazapyr, applied as the acid or isopropylamine salt, which were reassessed in 
2003. The reregistration review of imazapyr by U.S. EPA determined that the registered uses 
continued to meet the regulatory standards and the reregistration decision was issued in 2006 
(USEPA, 2006).  
 
 
 
2.3 Pesticide Type, Class, and Mode of Action  
Imazapyr is an imidazolinone herbicide that is used for control of most annual and perennial 
broadleaf weeds and grasses, woody species, and riparian and emergent aquatic weed species. 
This family of herbicides was discovered by American Cyanamid Company in the 1970's. 
Imazapyr is formulated both as an acid and as an isopropylamine salt. Uptake of imidazolinone 
herbicides is primarily through the foliage and roots. The herbicide is then translocated to 
meristematic tissue (buds or areas of growth) by the xylem and phloem where it inhibits 
acetohydroxyacid synthase [AHAS; also known as acetolactate synthase (ALS)], an enzyme 
involved in the synthesis of three essential amino acids (valine, leucine, isoleucine). These amino 
acids are required for protein synthesis and cell growth. Imazapyr disrupts protein synthesis and 
interferes with cell growth and DNA synthesis, causing the plant to slowly die. AHAS is not 
present in mammals, birds, fish, or insects, making it specifically toxic to plants (US EPA, 
2005A). 
 
2.4  Physical and Chemical and Environmental Fate Properties 
Important characteristics relative to the application of imazapyr in and near aquatic systems 
include the compound being an anionic, organic acid that is non-volatile and degrades through 
photolysis in clear shallow waters (US EPA Level I, 2005A). A summary of selected 
physical/chemical and fate properties for imazapyr and imazapyr isopropylamine salt is 
presented in Table 2.2.  
 
The herbicide imazapyr is a water soluble, weak acid with a pKa of about 3.8. Based on this pKa 
imazapyr is mainly in anionic form at typical environmental pHs (61% ionized at pH 4, 94% 
ionized at pH 5, greater than 99% ionized at pH 6 and higher). The behaviors of the acid and salt 
forms are expected to be similar. Commercial formulations contain imazapyr acid or the 
imazapyr isopropylamine salt, both of which are generally dissolved in a water solution. 
 
The environmental fate characteristics of imazapyr are that it is an anionic, organic acid (pKa = 
3.8) that is non-volatile, and is both persistent and mobile in soil. Laboratory studies show that 
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imazapyr is essentially stable to hydrolysis, aerobic and anaerobic soil degradation as well as 
aerobic and anaerobic aquatic metabolism. Imazapyr is not expected to bioaccumulate in aquatic 
organisms because it exists as an anion at typical environmental pH values  
Upon direct application, or indirect release into surface water, photolysis is the only identified 
mechanism for imazapyr degradation in the environment. The half-life of imazapyr is 
approximately 3 to 5 days in surface water. The major identified metabolites were pyridine 
hydroxy-dicarboxylic acid, pyridine dicarboxylic acid, and nicotinic acid. Under laboratory 
aerobic aquatic conditions, the aerobic aquatic metabolism half-lives for hydroxy-dicarboxylic 
acid and pyridine dicarboxylic acid were in the range of 3 to 8 days in two different 
sediment/water systems.  
 
Based on a low vapor pressure of <10-7 mm Hg at 60°C, volatilization is an unlikely route of 
dissipation from soil. Present as an anion at typical environmental pH values, imazapyr tends to 
be weakly sorbed to most soils and sediments. For anionic compounds, sorption would tend to 
diminish with increasing environmental pH. In several studies involving a total of 11 different 
soils and sediments, adsorption coefficients were low, as demonstrated by batch/bulk 
equilibrium sorption coefficients (KD) that range from 0.04 to 3.4 mL/g, with a median of 0.6 
mL/g. There was no apparent correlation with soil organic matter.  
Table 2.2. Some Physical, Chemical and Environmental Fate Properties of 
Imazapyr and the Isopropylamine Salt of Imazapyr.1 
Chemical name 
 
Acid      2-[4,5-Dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-3pyridinecarboxylic acid 
 
Salt       2-Propanamine, 2-(4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-3-pyridinecarboxylate 
 
Empirical Formula 
Acid                                      
Salt   
                                    
C13H15N2O3 
C13H15N2O3⋅C3H9N 
Molecular Weight 
Acid                                       
Salt 
         
261.28                           
320.39 
Aqueous Solubility at 25°C (acid)                 11.1 g/L 
pKa (acid)                                    3.8 
Vapor Pressure at 60°C (acid)                    <10-7 mm Hg 
Henry’s Law Constant at 25°C (acid)             <7 x 10-17 atm x m3/mol 
Log Pow at pH 7 and 20°C (acid)                  0.22 
Environmental Fate Properties 
Hydrolysis half life (pH 7)                         stable 
Aqueous photolysis half lives                 t ½ = 2.5 - 5.3 days 
Aerobic metabolism half-lives                      stable 
Anaerobic metabolism half-lives                    stable 
Soil-water distribution coefficients (Kd )   0.04 - 3.4 
1 Source: Table IIS-2 (p. 12) in Level I Screening Risk Assessment (US EPA, 2005A) 
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An environmental fate summary table is included in Appendix 2. Detailed descriptions of 
information on the environmental fate summaries and degradates can be found in Appendix A of 
Level I Screening Ecological Risk Assessment for Reregistration of Imazapyr (US EPA 2005A).  
Laboratory bioconcentration studies with bluegill sunfish, eastern oyster, and grass shrimp 
indicate that parent imazapyr, even though long-lived in the environment, is not subject to 
bioconcentration (bioconcentration factor <1). Imazapyr’s relatively high solubility in water and 
low n-octanol-to-water partitioning ratio is also consistent with little likelihood of 
bioconcentration.  
 
 
 
2.5  Product Formulation  
 
The product labels indicate that the Habitat and Imazapyr E Pro herbicide products are liquid 
formulations of isopropylamine salt of imazapyr at a concentration of 28.7% by mass, which 
corresponds to 2 lbs of acid equivalent per gallon of product (BASF, 2008; Etigra, 2007).  
 
According to information available in a review document on the use of imazapyr herbicide to 
control invasive cordgrass in the San Francisco Estuary (Pless, 2005), the inert ingredients in the 
Habitat herbicide are most likely similar to the composition of the Arsenal herbicide formulation 
and most likely include water and a small amount of acidifier. Information on the Habitat 
formulation obtained from the registrant confirms this. The formulation does not contain 
surfactants. No additional information was available on the Imazapyr E Pro formulation, but it 
can be expected to be very similar to the Habitat herbicide.  
 
The product labels indicate that treatment of post-emergent vegetation requires the addition of 
spray adjuvants to the tank mix. As directed on the label, only adjuvants  labeled for aquatic use 
should be utilized. Specific recommendations for adjuvants include those that contain non-ionic 
surfactants, methylated seed oils, and silicone-based surfactants. 
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3  Use Characterization 
 
3.1.  Use Sites 
 
Imazapyr is used for pre- and post-emergence control of a broad range of weeds, including 
terrestrial annual and perennial grasses, broad-leaved herbs, woody species, and riparian and 
emergent aquatic species. 
 
The focus of this special review is on the use as an herbicide for direct application to lakes and 
ponds. Aquatic uses of imazapyr are for control of undesirable emergent and floating aquatic 
vegetation in and around standing and flowing water including estuarine and marine sites. These 
include control of undesirable wetland, riparian and terrestrial vegetation growing in and around 
standing and flowing water.  
 
Imazapyr is also applied terrestrially on field corn and grass, a variety of commercial and 
residential use sites, including forestry sites, rights-of-way, fence rows, hedge rows, drainage 
systems, outdoor industrial areas, outdoor buildings and structures, domestic dwellings, paved 
areas, driveways, patios, parking areas and walkways. Imazapyr may also be used as a spot 
treatment in recreation areas, athletic fields, and golf course roughs (US EPA, 2006).  
 
The product labels provide language related to the use sites where the product can be applied 
including the following:  
 
• Aquatic use applications can only be made by federal or state agencies, such as Water 
Management District personnel, municipal officials and the U.S. Army Corps of 
Engineers, or those applicators who are licensed or certified as aquatic pest control 
applicators and are authorized by the state or local government. 
 
• Treatment to other than non-native invasive species is limited to only those plants that 
have been determined to be a nuisance by a federal or state government entity. 
 
• Applications may be made to private waters that are still, such as ponds, lakes and 
drainage ditches where there is minimal or no outflow to public waters. 
 
• Applications may be made to public waters such as ponds, lakes, reservoirs, marshes, 
bayous, drainage ditches, canals, streams, rivers, and other slow-moving or quiescent 
bodies of water for control of aquatic weeds or for control of riparian and wetland weed 
species. 
 
• There are no restrictions on the use of water in the treatment area for recreational 
purposes, including swimming and fishing. There are no restrictions on livestock 
consumption of water from the treatment area. 
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3.2.  Application Methods 
 
Aquatic applications of these imazapyr herbicide products are made as a liquid. Application 
methods include aerial application and application via boat. Aqueous imazapyr formulations may 
be mixed with surfactants or oils for application. Applications to smaller areas may be made with 
handheld equipment, including backpack sprayers, sprinkling cans, and handgun sprayers.  
 
Habitat and Imazapyr E Pro maybe be selectively applied by using low-volume directed 
application techniques or may be broadcast applied by using ground equipment, water craft or by 
helicopter. In addition, the products may also be used for cut stump, cut stem and frill and girdle 
treatments within aquatic sites. Applications should be made in such a way as to maximize spray 
interception by the target vegetation (moisten but not drench) while minimizing spray drift and 
the amount of overspray that enters the water (US EPA, RED, 2006).  
 
The products must be applied to the emergent foliage of the target vegetation and have little to 
no activity on submerged aquatic vegetation. The product concentrations resulting from direct 
application to water are not expected to be of sufficient concentration or duration to provide 
control of target vegetation. Application should be made in such a way as to maximize spray 
interception by the target vegetation while minimizing the amount of overspray that enters the 
water.  
 
 
3.3.  Use Rates 
 
Labeled application rates of imazapyr for aquatic sites range from 0.5 to 1.5 acid equivalent per 
acre (lbs a.e./acre).  
 
 
 
3.4.  Target Species 
 
Imazapyr-based herbicides will control various floating, emerged and terrestrial/marginal weed 
species.  It is effective against aquatic problem species such as alligator weed, Arundo donax, 
cattail, parrot feather, Phragmites, purple loosestrife, saltcedar, Spartina, water hyacinth, and 
water primrose. A complete list of weeds controlled can be found on the product label (BASF, 
2008; Etigra, 2007). 
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4. Human Health Risk Assessment 
 
4.1. Summary of USEPA Assessment 
 
As part the registration review, USEPA has conducted human health risk assessments for 
imazapyr. The risk conclusions of these assessments are summarized below. Appendix 3 
provides the summary of the USEPA’s revised human health effects and ecological risk 
assessments for imazapyr, as presented fully in the documents, Imazapyr: HED Chapter of the 
Reregistration Eligibility Decision Document, dated December 8, 2005 and Reregistration 
Eligibility Decision for Imazapyr (RED), US EPA (2006).  
 
The HED abstract states that imazapyr is of low toxicity via the oral, dermal, and inhalation 
routes of exposure. Toxicity studies reveal no effects to minimal effects, even at the highest dose 
tested in toxicological studies. Imazapyr is a Toxicity Category 1 primary eye irritant. Chronic 
dietary exposure to residues of imazapyr, including residues in drinking water, is not of concern 
for any population subgroup, including the US general population, females 13-49 years of age, 
children, and infants. There is the potential for exposure to occupational and residential handlers 
of imazapyr, although dermal and inhalation risks are below HED’s level of concern for all 
scenarios. Post-application exposures (including incidental oral exposure to toddlers, and oral 
and dermal exposure from swimming activities in treated lake water) are also below HED’s level 
of concern. Short- and long-term aggregate risks are not of concern. 
The chronic oral reference dose (cRfD) for imazapyr of 2.5 mg/kg/day was established based on 
a No-Observed-Adverse-Effect-Level (NOAEL) of 250 mg/kg/day, the highest dose level tested 
in the 1-year dog feeding and an Uncertainty Factor (UF) of 100 to account for both the 
interspecies extrapolation and intraspecies variability. An acute RfD could not be established 
because no appropriate endpoint attributable to a single dose was available (USEPA, 2005B). 
 
Summaries of the human health risk assessments as presented in the HED document (USEPA, 
2005B) and the RED document (USEPA, 2006) referred to above are available in Appendix 3. 
Relative to the aquatic use pattern, the risk related to recreational uses of treated water bodies 
and the risk associated with drinking water exposure are addressed and summarized below. 
 
4.2 Recreational Uses  
 
Imazapyr may be applied by broadcast application to aquatic freshwater sites to control floating or 
emergent aquatic vegetation. Adults and children may be exposed when swimming in treated 
water bodies following application of imazapyr. The potential for post-application incidental 
ingestion and dermal exposure to adults, children, and toddlers as a result of swimming in treated 
waters immediately following application has also been assessed. Post-application risks to adults, 
children, and toddlers swimming in imazapyr-treated waters are below the Agency’s level of 
concern (i.e., MOEs greater than 100) with MOEs ranging from 68,000 to greater than 1,000,000. 
More information on the risk assessment for recreational use on aquatic sites can be found in 
Appendix 4. 
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4.3 Drinking Water Assessment 
USEPA considered the exposure to imazapyr from drinking water resulting from aquatic applications. 
The estimated drinking water concentrations (EDWC’s) for both surface and ground water from direct 
application to surface water are both 61 µg/L (USEPA, 2005B). This estimate does not take into 
account the current imazapyr label requirement of a one-half mile setback from drinking water intakes 
because the Agency does not currently have an approved methodology for calculating EDWCs in 
water bodies where pesticides are applied with a setback distance from drinking water intakes. As a 
result, the EDWC is more conservative than had setback distances been considered. Direct 
applications to water were modeled assuming uniform application over an entire reservoir at the 
maximum labeled rate.  
The exposure from drinking water was considered with the aggregate risk assessment based on 
the combined exposures from food, drinking water, and, if applicable, residential exposure.  The 
chronic risk from food plus drinking water was assessed by exposure estimates from chronic 
dietary (food) and chronic drinking water assessment (USEPA, 2006). The combined chronic 
exposure for the general U.S. population and all population subgroups was less than 0.1 % of 
chronic Population-Adjusted Dose (cPAD). The cPAD for imazapyr is 2.5 mg/kg/day (see also 
Appendix 3). 
 
For imazapyr, the aggregate risk assessments were conducted for the short-term (food + drinking 
water + short-term residential) and for the long-term (food + drinking water only). Based on the 
current use patterns of imazapyr, USEPA does not expect exposure durations that would result in 
intermediate- or long-term residential exposures; therefore long-term aggregate risk assessment 
consisted of exposure from food and drinking water only.  
 
For adult short-term aggregate exposure, the Agency aggregated chronic food and drinking water 
exposures with residential handler and post-application exposures. The adult residential exposure 
scenarios resulting from application and post-application activities on turf were used. For short-
term aggregate exposure to children, the Agency aggregated chronic food and drinking water 
exposures for toddlers (1-2 years of age) and combined these with post-application dermal and 
incidental oral exposures (combined hand-to-mouth, object-to-mouth, and soil ingestion) from 
activity on turf. The estimated MOEs are above 100, with values of 410 for children and 720 for 
adults. Therefore, short-term aggregate risks are below the Agency’s level of concern. Because 
the Agency does not expect chronic residential exposure, long-term aggregate risks are equal to 
chronic dietary risks (food plus water) as described above. For a complete discussion, see also 
Section 7 of the Imazapyr: HED Chapter of the Reregistration Eligibility Decision Document 
(USEPA, 2005B). 
For the review presented here, an additional drinking water risk assessment was done by 
considering the health-based screening level for imazapyr. Health-Based Screening Levels 
(HBSLs)2 are benchmark concentrations of contaminants in water that may be of potential 
concern for human health, if exceeded. HBSLs are non-enforceable benchmarks that were 
developed by the USGS in collaboration with USEPA and others using USEPA methodologies 
                                                 
2 For more information on HBSLs see: USGS Health-Based Screening Levels 
 11 
 
Massachusetts Department of Environmental Protection  Massachusetts Department of Agricultural Resources 
for establishing drinking-water guidelines and the most current, USEPA peer-reviewed, publicly 
available human-health toxicity information (Toccalino et al., 2008).  
 
For noncarcinogens, the HBSL represents the contaminant concentration in drinking water that is 
not expected to cause any adverse effects over a lifetime of exposure. HBSL calculations adopt 
USEPA assumptions for establishing drinking-water guidelines, namely, lifetime ingestion of 2 
liters of water per day by a 70-kilogram adult. For non-carcinogens, it also is assumed that 20 
percent of the total contaminant exposure comes from drinking water sources and that 80 percent 
comes from other sources (for example, food and air). If data are available to quantify the 
percentage of contaminant exposure that comes from water, then a data-derived percentage is 
used instead of the default of 20 percent. More information on the calculation of HBLSs can be 
found on the USGS website (USGS Health-Based Screening Levels). 
Comparisons of measured or estimated contaminant concentrations in water to HBSLs can 
indicate when measured concentrations may be of potential human-health concern and can 
provide an early indication of when contaminant concentrations in ambient water resources may 
warrant further study or monitoring.  
The HBSL that has been established for imazapyr is 20,000 ug/L. The estimated drinking water 
concentration considered in the risk assessment by USEPA was 61 µg/L (USEPA, 2005B). This 
value is well below the HBSL of 20,000 µg/L and therefore is not of concern.  
 
Associated with the application of imazapyr to surface water, is a concern for the imazapyr to 
travel with surface water recharging groundwater that may subsequently be used as drinking 
water. A conservative screening-level risk assessment can be made by considering the recharge of 
groundwater with surface water with no attenuation of imazapyr concentrations. Estimated 
surface water concentrations of imazapyr one month after application can be used as a surrogate 
for worst case drinking water concentrations over an intermediate duration. The values in Table 
5.1 in Section 5.2.1 show a predicted range of 25 to 40 µg imazapyr/L. These values are well 
below the HBSL of 20,000 µg/L indicating that this exposure route is not of concern. Even the 
short-term peak concentrations (84 to 552 µg/L) would be below the HBSL. Degradation would 
also take place in the surface and ground further reducing the imazapyr concentrations.  
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5.0  Ecological Risk Assessment 
USEPA conducted an ecological risk assessment as part of the evaluation associated with the 
reregistration of imazapyr. This risk assessment is described in Level I Screening Ecological Risk 
Assessment for the Registration of Imazapyr (USEPA, 2005A), which is a technical support 
document for the RED for imazapyr. For the purpose of the special review presented here, the 
information most relevant to the evaluation of the aquatic use pattern is included below.  
 
The imazapyr analysis consisted of evaluating environmental fate data, modeling exposure 
concentrations, and evaluating toxicity information to characterize potential risks to the defined 
endpoints. The analysis is based on screening-level modeling of estimated exposure 
concentrations combined with information from imazapyr toxicity studies.  
 
5.1 Ecological Hazard Characterization  
 
5.1.1  Active Ingredient Imazapyr 
The Level I Screening Risk Assessment document (USEPA, 2005A) summarizes the effects 
characterization as described below. The acid and salt moieties for imazapyr are expected to 
behave similarly; therefore, they are used interchangeably. In order to communicate whether the 
acid or salt form of imazapyr was tested, the results of the ecotoxicity studies were expressed in 
terms of either active ingredient (a.i.) or acid equivalents (a.e.).  
Aquatic animals: Available acute toxicity data for aquatic species indicate that imazapyr acid is 
practically non-toxic to fish and invertebrates with LC50 and EC50 values for fish and 
invertebrates >100 mg a.i./L. Following chronic exposure, a decrease in larval survival was 
observed in freshwater fish (NOAEC/LOAEC = 43.1/92.4 mg a.i./L). There were no other 
observed adverse effects to freshwater fish or invertebrates following chronic exposure to 
imazapyr acid. Estimated chronic effects for estuarine/marine fish and invertebrates are uncertain 
because no chronic data were submitted by the registrant. The NOAEC values for 
marine/estuarine fish and invertebrates were derived based on the assumption that freshwater and 
estuarine/marine fish and freshwater and marine/estuarine invertebrates are of equal sensitivity. 
Available studies on aquatic animals with the isopropylamine salt indicate that the salt is no more 
toxic than the acid.  
The only sublethal effect observed in the acute aquatic animal studies is a decrease in shell 
deposition in the eastern oyster. The NOAEC/LOAEC for this effect was 109/173 mg/L. No other 
sublethal effects were observed in the aquatic animal studies. 
Laboratory bioconcentration studies with bluegill sunfish, eastern oyster, and grass shrimp 
indicate that parent imazapyr, even though long-lived in the [terrestrial] environment, is not 
subject to bioconcentration (bioconcentration factor <1). Therefore, food-chain exposures are not 
expected to be significant in aquatic systems.  
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Aquatic Plants: Studies indicate that imazapyr acid is highly toxic and expected to exert 
detrimental effects to aquatic vascular plants at the maximum application rate up to 1.5 lbs 
ae/acre. The EC50 for the aquatic vascular plant (duckweed) is 0.024 mg a.e./L (NOAEC 0.01 
mg/L), based on inhibition of plant growth and reduction of frond count. The toxicity of the 
isopropylamine salt to duckweed was similar to the acid, with a 14-day EC50 of 0.018 mg ae/L 
(NOAEC = 0.011 mg ae/L).  
Avian and Mammalian Toxicity: Available acute and chronic toxicity data indicate that 
imazapyr acid is practically non-toxic to upland game birds and waterfowl (acute LD50 >2,150 
mg ae/kg bw for both bobwhite quail and mallard ducks and the acute dietary LC50 >5000 mg 
a.i./kg diet for both bobwhite quail and mallard ducks). Chronic NOAECs for bobwhite 
quail/mallard duck = 1,670/>2000 mg a.i./kg diet, highest concentrations tested). Acute and 
chronic toxicity data also indicate that imazapyr acid is practically non-toxic to mammals. 
(Acute LD50 value of >5,000 mg a.i./kg bw; rat reproduction study NOAEL = 738 mg a.i./kg 
bw/day: 10,000 ppm, highest concentration tested). Acute and subacute exposures did not cause 
sublethal effects in mammals. Acute contact studies indicate that imazapyr acid is practically 
non-toxic to honey bees (LD50 > 100 µg a.i./bee). Available studies on terrestrial animals with 
the isopropylamine salt indicate that the salt is no more toxic than the acid.  
Terrestrial Plants: Terrestrial plant toxicity studies with monocots and dicots indicate that 
seedling emergence and vegetative vigor are severely impacted by exposure to imazapyr acid and 
to the isopropylamine salt of imazapyr. Seedling emergence, based on “fresh weight”, was 
adversely impacted in monocots (wheat) at an EC25 of 0.0046 lb ae/acre (0.52 mg ae/m2) and in 
dicots (sugar beet) with an EC25 of 0.0024 lb ae/acre (0.27 mg ae/m2). In the wheat, severe 
stunting, interveinal chlorosis, and cessation of growth occurred at doses >0.0078 lb ae/acre (0.88 
mg ae/m2). After 28 days, imazapyr acid resulted in >60% crop injury in sugar beets at all doses 
>0.031 lb ae/acre (3.48 mg ae/m2). Vegetative vigor in monocots, based on “fresh weight”, was 
adversely impacted by both imazapyr acid and the isopropylamine salt of imazapyr at an EC25 of 
0.012 lb ae/acre (1.35 mg ae/m2) in wheat and 0.010 lb ae/acre (1.12 mg ae/m2) in onion, 
respectively. In vegetative vigor studies with dicots, imazapyr acid was more toxic than the 
isopropylamine salt of imazapyr with EC25 of 0.0009 lbs ae/acre (0.10 mg ae/m2) (cucumber) and 
0.0016 lbs ae/acre (0.18 mg ae/m2) (sugar beet), respectively. Non-lethal effects included 
stunting, chlorosis, and necrosis. 
Metabolites: Metabolites hydroxy-dicarboxylic acid and pyridine dicarboxylic acid are expected 
to be more polar, thus more rapidly excreted than imazapyr, and no more toxic than the parent 
compound. Additionally, pyridine hydroxy-dicarboxylic acid is considered to be less stable than 
the parent compound. Nicotinic acid is a possible neurotoxin at high dose levels, but there is no 
concern for these effects at low exposures. Nicotinic acid (also called niacin and referred to as 
Vitamin B3) is considered an essential nutrient.  
 
A summary of ecological effects data from Level I Screening Level Risk Assessment can be 
found in Appendix 6. 
 
EPA typically uses fish as a surrogate for aquatic-phase amphibians when amphibian toxicity data 
are not available. In the case of imazapyr, no acute or chronic toxicity data are available for 
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aquatic-phase amphibians. EPA conducted a comprehensive assessment of the risks of imazapyr 
use to federally-listed California Red Legged Frog (CRLF), Rana aurora draytonii (Hurley and 
Shanaman, 2007). Fish were used as a surrogate to estimate direct acute and chronic risk to 
aquatic-phase CRLF. The risk assessment indicated that no direct effects are expected on either the 
aquatic or terrestrial phase CRLF. There are also no indirect effects expected for the CRLF through 
direct effect to either its terrestrial or aquatic food sources. The CRLF may be adversely affected 
through direct effects on habitat and ecosystem structure.  
 
Trumbo (unpublished) exposed bull frog tadpoles to imazapyr solutions for 96 hours. The reported 
96-h LC50 concentration for imazapyr acid was 799.6 mg ae./L, indicating that imazapyr is not 
very toxic to bull frog tadpoles. 
 
 
5.1.2  Adjuvants 
The toxicity of adjuvants was considered in risk assessments of imazapyr herbicide applications in 
estuaries in Washington State (Entrix, 2003) and San Francisco (Pless, 2005). Commonly used 
adjuvants included non-ionic alkylphenol ethoxylates and/or fatty acids (e.g., R-11®, X-77®), and 
crop-oil based concentrates (e.g., Agri-Dex®, Hasten®). On the basis of EPA toxicity criteria, the 
non-ionic alkylphenol ethoxylates (e.g., R-11®, X-77®) are moderately acutely toxic to aquatic 
species. The crop-oil based surfactants would be considered practically non-toxic. Smith et al. 
(2004) characterized the toxicity of four surfactants to juvenile rainbow trout and implications for 
their use over water. The 96-h LC50 values were 6.0 mg/L for R-11®, 17 mg/L for LI 700®, 74 
mg/L for Hasten, and 271 mg/L for Agri-Dex®. The 96-h EC50s (on-bottom gilling behavior) were 
4.4 mg/L for R-11® and 17 mg/L for LI 700®.  
 
Curran (2003) determined the toxicity of formulated herbicide product Arsenal Herbicide (a.i., 
imazapyr) with and without the adjuvants Agri-Dex® and Hasten® using juvenile rainbow trout. 
The 96-h LC50 value for Arsenal Herbicide without adjuvant was 77,716 mg/L. In systems 
containing Arsenal plus adjuvant, the 96-h LC50 was expressed as mg/L surfactant and were 
reported to be 113 mg/L for Hasten® and 479 mg/L for Agri-Dex®. These values were compared 
with the LC50 values for the surfactants alone which were 74 mg/L for Hasten® and 271 mg/L for 
Agri-Dex®. Since this source of information was a meeting abstract, no further evaluation of data 
was possible for the review presented here. The authors concluded that the data suggest that the 
Arsenal Herbicide formulation has low toxicity to juvenile rainbow trout, the toxicity the tank 
mixes is driven by the surfactants, and depending on the type of surfactant and its percentage in the 
tank mix, surfactants may pose greater hazard to non-target species than Arsenal Herbicide.  
Adjuvants and surfactants were also considered in human health and ecological effects risk 
assessments of imazapyr use for controlling vegetation in riparian corridors (AMEC, 2009). The 
most frequently used adjuvants were identified to be Agri-Dex®, Dyne-Amic®, Class-Act® and 
R-11®. It should be noted that the assessment did not consider direct applications to water. 
Reference was made to a study by Smith et al. (2004), which was cited above. While toxicity data 
were reviewed, the document did not include a formal exposure and risk assessment for the 
adjuvants.  
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5.2  Aquatic Exposure Assessment for Direct Applications to Water 
5.2.1  Active ingredient Imazapyr 
The Level I screening level risk assessment document (USEPA, 2005A) describes a procedure for 
estimating the environmental concentration following an application of imazapyr directly to the 
entire surface of the standard pond following uniform mixing throughout its volume. The 
maximum concentration of imazapyr was calculated, as described below, by simply dividing the 
total mass of pesticide applied to the pond by its volume. The “standard pond” has a surface area 
of 1.00 hectare and is 2.00 meters (6.56 feet) deep, and therefore it has a volume of 20,000 cubic 
meters or 2.00 x 107
 
liters (L). The maximum imazapyr application rate derived from the label is 
1.50 lb/acre, and since 1.00 lb/acre is equivalent to 1.121 kg/ha, the application rate is equivalent 
to 1.682 kg/ha or 1.682 x 109 µg/ha or 168.2 mg/m2 Thus, the peak concentration for imazapyr 
applied to water 2 meters deep is:  
(1.682 x 109 µg/ha x 1.00 ha)/(2.00 x 107 L) = 84.1 µg/L 
By simple proportional dilution calculations for theoretical lakes with shallower water depths (0.3 
m [1 ft], and 0.9 m [3.0 ft]) , and assuming no attenuating factors such as foliar interception, 
direct application at the maximum rate of 1.50 pounds a.i./acre to the entire surface area of these 
lakes would produce acute, peak concentrations of 552 and 184 µg/L, respectively.  
 
In order to estimate imazapyr concentrations in the pond as a function of time, the Environmental 
Fate and Effect Division (EFED) of US EPA used the Generic Estimated Environmental 
Concentration (GENEEC) model as described in the Level I screening risk assessment (US EPA, 
2005A). The GENEEC2 model is designed to simulate the ecological exposure to aquatic 
organisms from runoff and spray drift of chemicals applied terrestrially on an adjacent field. To 
assess the exposure for direct application of imazapyr to a water body, EFED had to adjust the 
GENEEC2 modeling routine and use proportionality factors to yield simulated concentrations that 
matched the directly calculated peak concentration values. The model predicted essential the same 
concentration levels   with time; for example, in a 1-ft deep water body, the concentration was 
predicted to decrease from the peak concentration of 552 µg/L to 549 µg/L at 21 days and 542 
µg/L at 60 days.  
For the purpose of the review presented here, the change in concentration with time was modeled 
with the AQUATOX model, an alternative water model that is available from USEPA. 
AQUATOX is an ecosystem simulation model that predicts the fate of various pollutants, such as 
excess nutrients and organic chemicals, and their effects on aquatic ecosystems. It has the 
capability to estimate the concentration in a water body from direct application of pesticides to a 
water body. An overview of the model is given in Appendix 5. The fate portion of the model was 
used here to characterize the dissipation of imazapyr following an application to a standard pond. 
EECs3 for aquatic uses were calculated for the direct application to the surface of standing water 
bodies of 1.0 ft (0.30 m), 3.0 ft (0.91 m), 3.94 ft (1.2 m) and 6.6 ft (2.0 m depths (Appendix 5). 
The 6.6 ft (2.0 m) depth is representative of the water depth in the standard pond scenario used by 
EFED for most ecological effects assessments. The 1 and 3 foot water depths are typical of use 
conditions in irrigation and drainage ditches, and for edge of pond depths, where problematic 
                                                 
3  EEC – estimated environmental concentration 
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aquatic weeds are typically found. The 3.94 ft depth was included since it is the depth in the 
model scenario used in AQUATOX (a Missouri farm pond).  
Detailed information on the model input and results can be found in Appendix 5. Figure 5.1 
shows the modeled imazapyr concentration and dissipation in a 3-ft deep pond. Similar trends in 
concentration and dissipation were found with the other pond depths (Appendix 5, Fig. A5-1 
through Fig. A5-4). The model results indicate that dissolved imazapyr dissipates in large part 
within a month following the application and that dissipation of imazapyr is primarily the result of 
photolysis (Fig. 5.1). The modeling was done with the longest photolysis half-life value of 5.3 d.  
  
 
 
Figure 5.1. AQUATOX model-predicted imazapyr concentration and dissipation in standard pond with 3 
ft depth. Application of 1.68 kg imazapyr (1.5 lbs/acre) was on May 10th. See Appendix 5 for modeling 
details and additional modeling results. 
  
 
Table 5.1. Summary of the AQUATOX model estimated concentrations of imazapyr 
concentration in the standard pond with the depths as described above and in Appendix 5.  
Depth  Concentration (µg/L) 
ft m  Peak 1 Month 2 Months 
6.6  2.0  81.6 25 4.4 
3.9  1.2  134 28 2.8 
3.0  0.91  174 25 1.4 
1.0  0.30  516 40 0.9 
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The depth of the pond appears to be an important factor in the dissipation rate of imazapyr 
in the pond water. Application of the herbicide in a shallow pond results in a higher peak 
concentration. On the other hand, more intense light penetration in a shallow pond will result in a 
higher photolysis rate (Appendix 5, Fig. A5-6). The initial trend of higher peak concentrations 
with lower depth is reversed after 2 months when deeper ponds show slightly higher residual 
concentrations. This may be attributed to the lower photolysis rate in deeper ponds (Fig. A5-6).  
The concentration trend after 1 month is intermediate to the trends observed in initial peak 
concentration levels and the residue levels after 2 months of dissipation. This may be the result of 
variation in dissipation due to differences in peak concentration and photolysis rate with pond 
depth. 
 
EFED also considered the exposure in a tidal open water bodies. In addition to applying imazapyr 
directly to the entire surface of the standard pond and the concentrations based on water depths, 
EFED also considered the potential of imazapyr to reach plants inhabiting semi-aquatic sites 
adjacent to or on the edge of the water body. In shallow-water communities, if imazapyr is 
applied to 1 foot depth of water (1 acre area), then some water moves onto land (i.e., berm washes 
out, boat wake sloshes water over bank, wind pushed water over berm, etc.). It was assumed that 
six inches of that water moves to a terrestrial site (1 acre area) where it dries up and deposits 
imazapyr on the ground. If 1.5 pounds were applied to 1 acre of the 1 foot of water, and half of 
that water moves (1 acre site) and dries, then 1.5, 2, or 0.75 pounds (lbs/acre) would have been 
deposited upon the 1-acre terrestrial site where the water moved. If the entire amount of water is 
moved from the aquatic site to the terrestrial site, where it dried, then the entire 1.5 pounds would 
have been deposited to that acre. In open water bodies, if imazapyr is applied (1.5 lbs/acre) to one 
acre of a tidal area at low tide, and the incoming tide pushes the entire amount of water to an acre 
of intertidal zone, then 1.5 lbs/acre would have been deposited. If a 6.6-feet depth of tide comes in 
on that one acre and 6 inches of that water would overflow to flood an intertidal zone terrestrial 
site, then 6 inches (0.5 feet) of the 6.6 feet of water would move. The amount of imazapyr 
deposited upon the terrestrial site would be 1.5 lbs/acre × (0.5/6.6) = 0.11 lbs/acre. If one foot of 
that 6.6-feet depth of tide moves, then there would be twice the amount of deposition, or 1.5 
lbs/acre × (1.0/6.6) = 0.23 lbs/acre (US EPA, 2005A).  
 
 
5.2.2  Adjuvants 
The application of Habitat and Imazapyr E Pro to post-emergent vegetation requires the addition 
of an adjuvant to the tank mix. As pointed out in the review for imazapyr use in the San Francisco 
Estuary (Pless, 2005), adjuvants may greatly increase the toxicity of the herbicide tank mix 
solution. Pless (2005) considered several adjuvants as used in tank mixes in the ecological risk 
assessment. The environmental properties and toxicity of adjuvants were also considered with the 
assessment of imazapyr herbicide use in estuaries in Washington State (Entrix, 2003). Both 
reviews considered estimated adjuvant concentration in water in an estuary scenario. For the 
purpose of this special review presented here, the environmental concentration of two adjuvants 
Agri-Dex® and Hasten® was estimated in a pond scenario as described below.  
 
It was assumed that the adjuvant was used in a 1% v/v concentration in the tank mix (the label 
requires >0.25%). It was further assumed that the application volume was 50 gallons per acre 
(label requirement is >5 gal for ground applications). A 1% v/v adjuvant concentration in the 50 
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gal spray volume would correspond to a 1.89 L adjuvant volume per acre. Based on the density of 
Agri-Dex (0.879 kg/L, Agri-Dex MSDS), this volume corresponds to 1.66 kg Agri-Dex adjuvant 
per acre. The peak concentration of Agri-Dex® in a 1-acre water body with a 1-foot depth can be 
calculated as follows: 1.66 × 106 mg / (4047 m2 × 0.3048 m × 1000 L/m3) = 1.35 mg/L. For the 
6.56-feet (2-meter) and 3-feet depths the concentrations are 0.21 mg/L(mg/L) and 0.45 
mg/L(mg/L), respectively. The values for another commonly used adjuvant Hasten® are very 
similar for the same adjuvant concentration given that the density of Hasten® is very similar 
compared to Agri-Dex (0.9 kg/L, Hasten® MSDS). It should be noted that these calculations 
assumed no interception by target vegetation and no sorption to sediment. The adjuvant 
concentrations calculated above are slightly lower than the values for adjuvant concentrations that 
were reported in Entrix (2003). Those calculations assumed a density of 1 kg/L, whereas the 
actual density of the adjuvant products Agri-Dex® and Hasten® is less than 1 kg/L.  
 
 
 
5.3.  Field Studies on Environmental Fate and Exposure of Imazapyr 
 
Studies that were conducted by the registrant to support the product registration indicated shallow 
pond dissipation half-lives in the range of 5 to 15 days (cited in Mangels and Ritter, 2000). 
Mangels and Ritter (2000) characterized the dissipation of imazapyr in flowing water bodies 
(canal, river) and lake settings by model simulations using a range of environment variables to 
represent a variety of conditions that could occur in different water bodies. The application 
scenario considered an application of imazapyr at the maximum rate of 1.5 lbs ae per acre to 
emerged, established vegetation on, in, or near water, based on which it was assumed that 75% of 
the applied product was intercepted by the vegetation. The simulations were performed using the 
Exposure Analysis Modeling System (EXAMS II) and modeling scenarios representative of 
applications in a flowing water body and a lake environment. The results for the flowing water 
body with the lowest velocity scenario (worst-case) indicated maximum concentrations at the 
edge of the treated area to be below 10 µg/L (ppb) within 8 hrs, below 5 µg/L within 2 d, and 
below 2 µg/L within 7 d. Under the highest velocity conditions, the imazapyr concentrations were 
below 5 µg/L within 1 hr. For the lake setting with the lowest dispersion rate (i.e., worst-case) 
scenario the maximum concentrations at the edge of the treated area were below 10 µg/L within 2 
d, below 5 µg/L within 4 d, and below 2 µg/L within 8 d. In the scenario with the highest 
dispersion rate, the concentrations were below 2 µg/L within 12 hrs.  
 
It appears that the registrant conducted studies in Florida and Missouri pond systems on the 
occurrence of imazapyr and its degradation products in tissues of bluegill, tilapia, catfish and 
crayfish. These data were described in the review by Entrix (2003) with reference to Mangels and 
Ritter (2000). However, this reference to Mangels and Ritter (2000) appears to be incorrect as is 
indicated by the description of that study above; the studies described in the Entrix (2003) review 
were most likely obtained from the registrant. Below is a summary of the information presented 
in the Entrix (2003) review. The ponds contained 75, 28, 213 or 261 µg/L imazapyr following 
treatments of Arsenal® herbicide to the banks and outer edges of the ponds at a rate of 1.5 lb 
ae/acre in spray solutions of 21 to 23 gal. Ultimate concentrations in the ponds varied due to 
dilutional profiles inherent to the ponds (e.g., volumes). The initial pond water concentrations 
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were in the range of 28 to 261 µg/L, the initial pond sediment concentrations were in the range of 
1.5 to 10.2 µg/L. The half-life of imazapyr in the pond water ranged from 3.9 days in the Florida 
pond to 14.5 days in the Missouri pond. Imazapyr residues were detected in fish samples in only 
one of the Missouri ponds taken at 3 hours post-treatment (0.636 ppm in bluegill, 0.233 ppm in 
catfish, 0.068 ppm in tilapia, and 0.059 ppm in crayfish). No residues were detected in fish 
samples taken at later times.  
 
As noted earlier, photodegradation is the dominant degradation process for imazapyr in surface 
water and it occurs relatively rapidly. Field dissipation experiments were conducted by the 
product registrant in shallow Florida and Louisiana freshwater pond systems. These studies were 
summarized in the document on the ecological risk assessment of the use of imazapyr to control 
cordgrass in estuarine habitat of Washington State (Entrix, 2003). Imazapyr (formulated as 
Arsenal) was applied to the surface of the water at 1.5 lb ae/acre. Dissipation (field degradation) 
was followed in water and sediment over 180 days. Figure 5.2 reflects study results from water 
and sediment analyses from the Louisiana pond study through the first 30 days of study, over 
which period the vast majority of dissipation had occurred. Similar results were obtained with the 
Florida pond system (not shown) although degradation was slightly faster and there did not 
appear to be the initial spike in the sediment concentration that was observed in the Louisiana 
pond system. The first-order half-lives in the water and sediment were 1.9 and 12.8 days, 
respectively. No detectable residues of imazapyr were found in the water and sediment after 14 
and 59 days, respectively. 
 
 
 
Figure 5.2. Residues of imazapyr in water and sediment from a Louisiana pond treated with 1.5 
lb ae/acre. (Source: Entrix, 2003) 
 
 20 
 
Massachusetts Department of Environmental Protection  Massachusetts Department of Agricultural Resources 
 
It should be noted that the results from the model simulations for environmental concentrations in 
Table 5.1 (Section 5.2.1) show a similar trend compared to the observations in field studies as 
described above. The somewhat longer dissipation time indicated by the AQUATOX model data 
depicted in Fig. 5.1 may be attributed to the modeling with the longest photolysis half-life of 5.3 
d. The reported range in photolysis half-life is from 2.5 to 5.3 d. Shorter photolysis half-life 
would result in faster dissipation.    
 
Patten (2003) studied the persistence of imazapyr when used to control cordgrass in an estuary. 
Imazapyr was applied at 1.68 kg ae/acre (1.5 lbs ae/acre) with 1% v/v Agri-Dex adjuvant. The 
persistence of imazapyr in water and sediment followed an exponential decay. The geometric 
mean of imazapyr concentration over 76 hours in the 0.6 to 20 m zone outside the spray area was 
0.1 mg/L (or 100 µg/L) in water and 3.2 µg/g in fresh weight sediment. It was stated that these 
concentrations were 5 to 6 orders of magnitude lower than levels needed to affect aquatic 
invertebrates and fish. The imazapyr levels in water and sediment approached non-detect levels at 
40 and 400 hrs, respectively, and the corresponding half-lives were reported in the range of <0.5 
and 1.6 days, respectively.  
 
The fate of imazapyr in mesocosm systems representing the situation in cypress domes in 
Southeastern United States was characterized in a study by Fowlkes et al. (2003). The half-life of 
imazapyr in these systems was in the range of 3.2 to 3.4 days.  
 
 
5.4 Risk Characterization 
 
5.4.1  Active Ingredient Imazapyr 
Ecological risk characterization integrates the exposure and ecotoxicity data to evaluate the 
likelihood of adverse ecological effects. Level I Screening Risk Assessment (US EPA, 2005A) 
was based on a deterministic approach to evaluate the likelihood of adverse ecological effects to 
non-target species. In this approach, risk quotients (RQs) are calculated by dividing EECs by 
ecotoxicity values for non-target species, both acute and chronic. RQs are then compared to 
established levels of concern (LOCs). These LOCs are criteria used by US EPA to indicate 
potential risk to non-target organisms and the need to consider regulatory action. 
 
Aquatic Organisms 
Available acute toxicity data for aquatic species indicate that imazapyr acid is practically non-
toxic to fish and invertebrates with LC50 and EC50 values >100 mg/L. The only sublethal effect 
observed in the acute aquatic animal studies was a decrease in shell deposition in the eastern 
oyster. The NOAEC/LOAEC for this effect was 109/173 mg/L. In order to compare these 
values with an exposure value, the highest peak EEC in surface water was selected from the 
aquatic uses, which utilize direct application to water. The EEC estimation assumes a 1-foot 
water depth. A comparison of the ecotoxicity values  of  100,000 – 173,000 µg/L with the peak 
EEC in surface water (552 µg/L) (Section 5.2.1), indicates a 181 to 313-fold difference between 
the highest estimated EEC and the concentrations which produced either no effects (100,000 – 
109,000 µg/L) or a decreased shell deposition in oysters (173,000 µg/L). The estimated peak 
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EEC in surface water from the granular uses is less than 552 µg/L. Therefore, it is concluded 
that the acute risk to fish and aquatic invertebrates is expected to be very low.  
Following chronic exposure, the NOAEC/LOAEC for freshwater fish is 43.1/92.4 mg/L and the 
NOAEC for freshwater invertebrates is 97.1 mg/L, the highest concentration tested. For aquatic 
uses (direct application to water, assuming 1 foot water depth), the highest chronic EECs as 
determined by USEPA-EFED are 549 µg/L (21 day) and 542 µg/L (60 day). Using the NOAEC 
of 43.1 mg/L (43,100 µg/L) for freshwater fish and the 60-day EEC of 542 µg/L, the RQ is 0.013. 
For invertebrates the RQ is 0.006. These RQ values are below the lowest LOC of 0.05 for acute 
risk to endangered aquatic animals. Note that the AQUATOX model estimated concentrations 
reported in Section 5.2.1 are much lower than the concentrations used by EFED. Consequently, 
the associated RQ values would also be lower.  
The risk estimation described above indicates that there is minimal risk of direct acute effects 
to fish and aquatic invertebrates. In addition, there are no chronic risks to fish and 
invertebrates. Consequently, fish and invertebrates inhabiting surface waters adjacent to an 
imazapyr treated field would not be at risk for adverse acute and/or chronic effects on 
reproduction, growth and survival when exposed to imazapyr directly or through residues 
from imazapyr applications.  
Regarding chronic risk, it was stated that there is an uncertainty for estuarine/marine fish and 
invertebrates, since no toxicity data were available to observe the prolonged effects of imazapyr 
to estuarine/marine fish and invertebrates. This area of uncertainty was addressed to some extent 
by an estuarine field study conducted by Patten (2003) which showed an exponential dissipation 
pattern (see Section 5.3). Patten (2003) also studied the osmoregulatory capacity of Chinook 
salmon (Oncorhynchus tshawytscha) smolts based on plasma sodium level and gill ATP-ase. The 
results indicated that it was not affected by imazapyr at concentrations up to 1600 µg/L.  
 
The RED4 document (USEPA, 2006) further includes the assessment that concludes that the 
imazapyr direct application to water scenario for aquatic uses indicated exceedances of the non-
endangered LOCs for vascular plants inhabiting various water depths (see Table 5.2). Likewise, 
endangered vascular plant LOCs were exceeded for the direct application to waters at all three 
depths considered. There were no LOC exceedances for non-vascular aquatic plants.  
 
  Table 5.2. Aquatic Plant Risk Quotient Summary for Aquatic Use 
Scenario Water Depth Non-endangered Endangered Non-Vascular Vascular Vascular 
Direct Application 
to Water (1.5 lbs 
a.e./acre) 
1 foot 0.048 31** 50* 
3 feet (0.91 m) 0.016 10** 17* 
6.6 feet (2 m) <0.01 4.7** 7.6* 
* indicates an exceedance of Endangered Species LOC (LOC=1). 
** indicates an exceedance of Acute Risk LOC (LOC=1). 
  
 
                                                 
4 RED – Reregistration Eligibility Decision  
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Terrestrial Organisms 
For birds as well as mammals, acute risk quotients were not estimated because there was no 
mortality or any other signs of toxicity in either the acute oral studies or the acute dietary studies. 
For terrestrial non-crop uses with spray applications of 1.5 lb ae/acre, the highest EEC 
concentration for birds is 410 mg/kg bw for short grass consumed by a 20 g bird. The adjusted 
LD50 for 20 g birds would be > 1,549 mg/kg bw. There is an approximately four-fold difference 
between these two values. Since there were neither mortalities nor clinical signs of toxicity at 
1,549 mg/kg bw, the acute risk to birds following spray applications is likely to be low. The 
chronic LOC for birds is not exceeded for any of the registered uses.  
For terrestrial non-crop uses with spray applications, the highest EEC concentration for mammals 
is 343 mg/kg bw for short grass consumed by a 15 g mammal. The adjusted LD50 for 15 g 
mammals would be >10,989 mg/kg bw. There is an approximately 32-fold difference between 
these two values. Since there were neither mortalities nor clinical signs of toxicity at 10,989 
mg/kg bw, the acute risk to mammals following spray applications is likely to be low. The 
chronic LOC for mammals is not exceeded for any of the registered uses.  
US EPA currently does not quantify risks to terrestrial non-target insects; however, available 
data on honey bees indicate that the risk to terrestrial non-target insects is likely to be low. 
Imazapyr acid and its isopropylamine salt have shown no indication of inducing endocrine-
related effects following exposure.  
The US EPA (2006) document summarized the ecological risk as follows: “There are no risks of 
concern to terrestrial birds, mammals, and bees, or to aquatic invertebrates and fish. However, 
there are ecological risks of concern associated with the use of imazapyr for non-target terrestrial 
plants and aquatic vascular plants, and potential risks to federally listed threatened and 
endangered species (“listed species”) which include aquatic vascular plants, terrestrial and semi-
aquatic monocots and dicots that cannot be precluded at this time.” 
 
For a complete discussion, see the Screening Level I Ecological Risk Assessment for the 
Reregistration Eligibility Decision Document for Imazapyr (US EPA, 2005A). Summary tables of 
the environmental risk conclusions and risk descriptions is included in Appendix 7. 
 
5.4.2  Risk Assessment of Adjuvants 
Adjuvants 
As pointed out in the review by Pless (2005), the toxicity of the herbicide/adjuvant mixture is 
driven by the surfactant. The risk quotients presented by Pless (2005), based on environmental 
concentrations in an estuary scenario, were in the range of 0.13-0.051. The higher value was 
determined in association with the adjuvant Hasten®. That value marginally exceeded the level of 
concern (LOC) of 0.05 for endangered fish. It was pointed out that the highest measured exposure 
was extremely conservative in that the pesticide was applied directly to the estuary sediment (mud 
flat) without interception by vegetation and measured in the 3 hours later in the first overflow.  
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For the consideration of the application in a pond, the estimated environmental concentrations 
(EECs) of the Agri-Dex® and Hasten® adjuvants were presented in Section 5.2.2. These two 
adjuvants were selected based on the availability of toxicity data for product with adjuvant (Curran 
et al., 2003). The highest estimated concentration in a water body with 1-foot depth was 1.35 
mg/L. Based on the 96-hr LC50 of 479 mg/L expressed as adjuvant (Curran et al., 2003) for the 
product plus adjuvant mixture, the risk quotient is 0.0028. For the Hasten® adjuvant, the risk 
quotient would be 0.012. These values are below levels of concern for aquatic species as 
established by USEPA (2011), the most sensitive for endangered species acute risk being 0.05.  
Entrix (2003) conducted a risk assessment of four adjuvants that have uses with glyphosate- and 
imazapyr-based aquatic herbicides. In addition to Hasten® and Agri-Dex®, the LI 700® and R-
11® were included in the exposure and risk assessment. Since the spray-volume requirements for 
glyphosate-based herbicide are higher compared to imazapyr-based herbicides, the risk quotients 
were evaluated as a function of spray volume. The risk quotients were based on the LC50 values for 
juvenile rainbow trout as reported by Smith et al. (2004). The same procedure was used here for 
the concentrations developed for a pond scenario as described in Section 5.2.2. Figure 5.3 shows 
that the R-11 adjuvant exceeds the most sensitive Level of Concern (LOC) over the entire 
application volume range considered, while the Hasten® and Agri-Dex® adjuvants do not exceed 
the most sensitive LOC even at the highest application volume. In the review by Entrix (2003), it is 
pointed out that glyphosate-based herbicides require large application volumes (up to 100 gal/acre 
for efficacy), while 5 to 20 gal/acre can be used for imazapyr-based herbicides to yield equivalent 
results. Consequently, imazapyr-based herbicide applications are associated with lower adjuvant 
exposures compared to glyphosate-based herbicides.  
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Figure 5.3. Risk quotient (RQ) of four spray adjuvants based on adjuvant concentrations associated with 
applications to a 1-foot deep water body. The adjuvant concentration was 1% v/v. The risk quotient was 
calculated based on the 96-h LC50 values for rainbow trout as reported by Smith et al. (2004). The RQ 
values are compared with the Levels of Concern (LOC) for acute risk as developed by US EPA (2011).   
Smith et al. (2004) estimated water depth at which the 96-h LC50 value for juvenile trout would be 
reached with an application volume of 20 gal/acre and labeled tank mix concentration (0.5 – 5%). 
The authors determined the water depths at which LC50 for the exposed trout would be  reached.  
When used at the minimum recommended percentage of adjuvant in the tank mix the LC50 depth 
was  <16 mm for R-11 and < 5 mm for the Agri-Dex®, Hasten® and LI 700®.  At the maximum 
label recommended percentages of adjuvant in the tank mix, the LC50    depth for Agri-Dex would 
remain <5 mm, for Hasten it would be 10 mm and for LI 700 it would be 43 mm. It was concluded 
that Agri-Dex posed the lowest hazards to fish among the surfactants evaluated.  
 
 
Acidifier 
The potential risk of the small amount of acidifier in the product formulation was evaluated in the 
reviews by Entrix (2003) and Pless (2005). It was stated that the toxicity of the acidifier to aquatic 
organisms can be classified as slightly toxic. It was concluded that the risk from the small amounts 
of acidifier in the product formulation and the even lower levels in the tank mix would not pose 
significant risks to aquatic organisms.  
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5.4.3  Uncertainties, Assumptions, Limitations and Data Gaps  
 
Every risk assessment has inherent uncertainties. The ecological risk assessment overview by US 
EPA (2011) states that in interpreting the risk, the risk assessor evaluates the lines of evidence 
supporting or refuting risk estimates in terms of the following factors: adequacy and quality of 
data, degree and type of uncertainty, and relationship of evidence to risk assessment questions. 
For a risk characterization to be useful to risk managers, it must be transparent, clear, consistent, 
and reasonable (the TCCR principles). 
 
Uncertainties, assumptions, strengths, limitations, and data gaps related to the ecological risk 
assessment of imazapyr herbicides is considered in the Level I screening risk assessment (US EPA, 
2005A) and in the review for Washington State (Entrix, 2003). Summarized below are some of the 
aspects considered to be most relevant to the special review present here.  
 
The exposure assessment was conducted assuming a worst-case scenario in which all of the 
applied spray solution was deposited on the water surface and subsequently mixed in the water 
column below. This assessment is most likely very conservative given that typical application of 
the spray solution toward the emerged target vegetation will result in interception of a large 
fraction of the spray solution. The estimated environmental concentrations, and consequently the 
associated risks, are therefore likely to be lower than the values outlined or described in the risk 
assessment reviewed here. 
 
 The review for use of imazapyr in Washington State (Entrix, 2003) describes uncertainties and 
data gaps relative to the risk assessment of imazapyr use in estuaries for control of cordgrass 
(Spartina). Even though the main data gaps were presented in the context of the risk assessment in 
an estuarine environment, they could be considered to have relevance to risk assessment for use of 
imazapyr in fresh water environments. Therefore, they are included and summarized below:  
 
• Studies pertaining to the effect of imazapyr on aquatic or water-dependent species other 
than fish, e.g., amphibians, are limited 
 
• Specific data on the toxicity of imazapyr to sediment-associated organisms typical of 
north temperate (marine) environments is generally lacking and represents a significant 
data gap 
 
• Residues of imazapyr in treated plant material and the degradation of the herbicide over 
time in plant tissue were not identified in the literature. Exposure calculations in this 
assessment therefore relied on estimated concentrations in the plant tissue. Empirical 
residues from plants would increase confidence in the exposure and risk estimates 
 
• Effects on the microrhizosphere and microflora in a treated water bodies (estuary) have 
not been explored. Long term implications of herbicide use on nutrient dynamics could 
affect microflora. 
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• Effects on non-target aquatic environment (salt-marsh) plants native to areas where 
invasive species, such as Spartina, has colonized are poorly understood. Limited data on 
only a few species have been reported. 
 
• Persistence and stability of imazapyr in dead and decaying vegetation is not known. Can 
leachate from decaying vegetation retain herbicidal activity thereby potentially delaying 
the recovery of native aquatic environment (salt marsh) plants? 
 
• Drift concentrations of imazapyr off-site by treatment method (e.g., backpack, boom 
sprayer, etc.,) have not been quantified. However, worst-case scenario exposure conditions 
in direct application sites did not indicate significant risk. 
 
• Effects on (marine) phytoplankton: could herbicide treatments affect nutrient transfer to 
higher trophic levels if phytoplankton are inhibited? 
 
• Effects on water-surface microlayer associated organisms and microflora in this surface 
water film are not known. 
 
 
The Entrix (2003) review states that while the above data gaps represent uncertainty, the existing 
information on the toxicity and fate of the compound is substantial and suggests that it would be 
unlikely that significant negative impacts would be found in studies addressing the above data 
gaps—with the possible exceptions of effects on other non-target plants and phytoplankton. 
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6. Risk Mitigation  
 
The potential movement from the application area and risk to non-target organisms is addressed by 
product label statements, including the following:  
 
Environmental Hazards 
Treatment of aquatic weeds may result in oxygen depletion or loss due to decomposition of dead 
plants. This oxygen loss may cause the suffocation of some aquatic organisms. Do not treat more 
than one half of the surface area of the water in a single operation and wait at least 10 to 14 days 
between treatments. Begin treatment along the shore and proceed outward in bands to allow 
aquatic organisms to move into untreated areas. Do not contaminate water when disposing of 
equipment washwaters or rinsate. This pesticide is toxic to vascular plants and should be used 
strictly in accordance with the drift precautions on the label. 
 
Precautions for Potable Water Intakes 
Do not apply these products directly to water within one-half mile upstream of an active potable 
water intake in flowing water (i.e., river, stream, etc.) or within one-half mile of an active potable 
water intake in a standing body of water such as lake, pond or reservoir. To make aquatic 
applications around and within one-half mile of active potable water intakes, the water intake 
must be turned off during application and for a minimum of 48 hours after the application. These 
aquatic applications may be made only in the cases where there are alternative water sources or 
holding ponds, which would permit the turning off of an active potable water intake for a 
minimum period of 48 hours after the applications.  
 
Application to Waters used for Irrigation 
Water treated with these products may not be used for irrigation purposes for 120 days after 
application or until product residue levels are determined by laboratory analysis, or other 
appropriate means of analysis, to be 1.0 ppb or less. 
 
Information Related to Application Methods  
Applications made to moving bodies of water should be made while traveling upstream to prevent 
concentration of this herbicide, in water. Do not apply to bodies of water or portions of bodies of 
water where emergent and/or floating weeds do not exist. 
When application is to be made to target vegetation that covers a large percentage of the surface 
area of impounded water, treating the area in strips may avoid oxygen depletion due to decaying 
vegetation. Oxygen depletion may result in the suffocation of some sensitive aquatic organisms. 
Do not treat more than one half of the surface area of the water in a single operation and wait at 
least 10 to 14 days between treatments. Begin treatment along the shore and proceed outward in 
bands to allow aquatic organisms to move into untreated areas. 
Avoid wash-off of sprayed foliage by spray boat or recreational boat backwash for one hour after 
application. 
 
Avoiding Injury to Non-Target Plants 
When making applications along shorelines where desirable plants may be present, caution should 
be exercised to avoid spray contact with their foliage or spray application to the soil in which they 
are rooted. Shoreline plants that have roots that extend into the water in an area where the 
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herbicide has been applied generally will not be adversely affected by uptake of the herbicide 
from the water. 
 
Managing Off-Target Movement 
To minimize spray drift, the label contains drift reduction advisory information address various 
equipment- and weather-related factors that determine the potential for spray drift. The factors 
addressed on the label include control of droplet size, application height, swath adjustment, wind, 
temperature and humidity, and temperature inversions.  
 
 
Additional restrictions may be imposed with the permitting of the use of these products in 
Massachusetts lakes and ponds. 
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Appendix 1 
Guide to Sources of Information Used for the Special Review of Imazapyr as a New Active 
Ingredient in Aquatic Herbicides for Use in Lakes and Ponds in Massachusetts. 
 
Documents related to EPA’s reregistration review of imazapyr are available in the e-docket 
OPP-2005-0495 at the regulation.gov website: search “all document types” for “OPP-2005-
0495” 
The following documents were included as information sources for the special review of 
imazapyr for use in lakes and ponds in Massachusetts:    
1. Reregistration Eligibility Decision (RED) Document for Imazapyr (2006) 
2. Imazapyr: HED Chapter of the Reregistration Eligibility Decision Document, dated 
December 8, 2005. 
3. Level 1 Screening Ecological Risk Assessment for the Reregistration of Imazapyr 
December 9, 2005 B Stephen Carey, Pamela Hurley, and Lucy Shanaman 
o APPENDIX A  Environmental Fate Summaries and Structures of Imazapyr 
Transformation Products- Level 1 Screening Ecological Risk Assessment for the 
Reregistration of Imazapyr  
o APPENDIX B   Aquatic Exposure Modeling for Terrestrial Applications 
(GENEEC2) - Level 1 Screening Ecological Risk Assessment for the 
Reregistration of Imazapyr  
o APPENDIX C  Calculation Methods and GENEEC2 Model Input/Output Tables 
Showing  Estimated Environmental Concentrations (EECs) for Direct Application 
to Water- Level 1 Screening Ecological Risk Assessment for the Reregistration of 
Imazapyr  
o APPENDIX E  Ecological Effects Data - Level 1 Screening Ecological Risk 
Assessment for the Reregistration of Imazapyr  
4. Tier I Drinking water concentrations (surface and ground water) for the herbicide 
imazapyr/Arsenal applied to terrestrial and aquatic environments. Kincade, S. et al., 
Office of Prevention, Pesticides, and Toxic Substances, Memo dated May 11, 2005.  
 
5. EPA Risk Assessment for California Red-legged Frog  
  Documents available at: Effects Determinations for the California Red-legged Frog and 
other California Listed Species | Endangered Species Protection Program: Pesticides | US 
EPA 
• Risks of Imazapyr Use to the Federally Listed California Red Legged Frog (2007) 
A1‐2 
 
• Appendix A: Environmental Fate  
• Appendix B: Ecological Effects Characterization 
 
 
6. US Forest Service Reviews 
Imazapyr: Human Health and Ecological Risk Assessment, 2004; Available at: 
http://www.fs.fed.us/foresthealth/pesticide/pdfs/121804_Imazapyr.pdf 
 
7. Washington State Reviews and Risk Assessments   
Ecological Risk Assessment of the Proposed Use of the Herbicide Imazapyr to Control 
Invasive Cordgrass (Spartina spp.) in Estuarine Habitat of Washington State. 2003. 
Available at: 
http://www.ecy.wa.gov/programs/wq/pesticides/final_pesticide_permits/noxious/risk_ass
essment_Imazapyr.pdf 
This document is also available at regulations.gov 
 
 
 
 
 
Appendix 2 
 
Environmental Fate Summary Table from Level I Screening Risk Assessment (US EPA, 2005A).
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Appendix 2.  Degradation and Metabolism of Imazapyr (source: Level I, US EPA, 2005) 
Study 
MRID Study Type System 
Imazapyr 
half-life 
Maximum transformation products (% of applied radiation) 
CL
288247 1 
CL
252974
CL
119060
CL
9140
CL
252974 5 
CO2
00132359 Hydrolysis (161-1) pH 5 at 25°C Stable ND2 ND ND ND ND ND
pH 7 at 25°C Stable ND ND ND ND ND ND 
pH 9 at 25°C Stable ND 6.9 ND ND ND ND
00131617 Photolysis in  water (161-2) pH 5 and 9 at 25°C 
(12 hour exposure cycle) 
2.5 - 5.3 days ND ND 9.7 22.7 ND NA3
40003713 Photolysis in soil (161-3) Loamy sand soil Stable
 (~149 days) 
ND ND ND ND ND NA
41023201 Aerobic Soil Metabolism (162-1) Loamy sand soil Stable ND ND ND ND ND 7
45119701 Aerobic Soil Metabolism (162-1) 
(Supplemental) 
Loamy sand soil (~5.9 years) 
>296 days ND 3 ND ND ND  6 
00131619 Anaerobic Soil Metabolism (162-2) Loamy sand soil Stable (>60 days) ND ND ND ND ND ND
40003712 Anaerobic Aquatic Metabolism 
(162-3) 
Total system >120 days ND ND ND ND ND ND 
41002301 Aerobic Aquatic Metabolism 
(162-4) 
Total system >120 days ND ND ND ND   ND 1.1 
45119702 Aerobic Aquatic Metabolism 
(162-4) - Degradate metabolism 
Total system 
(CL 119060 metabolism) 
(CL 9140 metabolism) 
4.9  days 
3.6  days 
NA
NA
NA
NA
NA
NA
20.4 
NA
ND
ND
44.9 
53
42192101 Terrestrial field dissipation (164-1) Bare ground / Silt loam soil
 Hillsboro, Oregon 
143 days NA NA NA NA NA NA 
42192102 Terrestrial field dissipation (164-1) Bare ground / Sandy loam soil 
Janesville, North Carolina 
64 days NA NA NA NA NA NA
40003714 Forestry Dissipation (164-3) Aerial application, 
residues measured 
12-40 days 
(vegetation) 
37-44 days 
(litter) 
NA NA NA NA NA NA
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Appendix 3 
Summaries of Human Health Risk Assessments from EPA documents: 
From RED (USEPA, 2006)  
 
III. Summary of Risk Assessment 
 
The following is a summary of the Agency’s revised human health effects and ecological 
risk assessment for imazapyr, as presented fully in the documents, Imazapyr: HED Chapter of the 
Reregistration Eligibility Decision Document, dated December 8, 2005, and Screening Level 
Ecological Risk Assessment for the Reregistration Eligibility Decision Document for Imazapyr, 
dated December 8, 2005.  The purpose of this summary is to assist the reader by identifying key 
features and findings of these risks assessments, and to help the reader better understand the 
conclusions reached in the assessments. 
 
The human health and ecological risk assessment documents and supporting information 
listed in Appendix C were used to reach the regulatory decisions for imazapyr.  While the risk 
assessments and related addenda are not included in this document, they are available in the 
Public Docket, under docket number OPP-2005-0495 and on the internet at 
http://www.regulations.gov.  Hard copies of these documents may be found in the OPP public 
docket under this same docket number. 
 
 A. Human Health Risk Assessment 
 
The Agency has conducted a human health assessment for imazapyr for the purposes of 
making a reregistration decision. The Agency evaluated toxicological and chemistry studies 
submitted for imazapyr and determined that the data are adequate to support a reregistration 
decision.  In addition, the Agency has conducted dietary, drinking water, residential, aggregate, 
and worker assessments to determine the potential risks associated with the use of imazapyr.  
More in-depth details of the health effects of imazapyr are provided in the human health risk 
assessment. 
 
For a complete discussion, see Section 6.0 of Imazapyr: HED Chapter of the 
Reregistration Eligibility Decision Document, dated December 8, 2005. 
 
  1. Hazard Profile 
 
The toxicological database for imazapyr is complete. Imazapyr has low acute toxicity via 
the oral (Toxicity Category IV) and dermal (Toxicity Category III) routes of exposure. Imazapyr 
has been placed in acute Toxicity Category II for the inhalation route of exposure.  It is not 
irritating to the skin, and is negative for dermal sensitization; however, imazapyr results in 
irreversible eye damage (Toxicity Category I) as seen in Table 1.  Normally, an acute hazard 
value is chosen from acute (non-lethal), subchronic, or developmental toxicity studies from which 
there is reasonable evidence that a single exposure can lead to a potential effect.  The available 
data suggest that a single exposure to imazapyr does not result in an effect of concern for risk 
assessment purposes.
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Table 1. Acute Toxicity Data for Imazapyr 
Guideline Number 
Study Type 
Toxicity Category 
870.1100 Acute Oral Toxicity IV 
870.1200 Acute Dermal Toxicity III 
870.1300 Acute Inhalation Toxicity II 
870.2400 Acute Eye Irritation 
I 
Tested with 99.3% 
technical fine 
powder 
870.2500 Acute Dermal Irritation IV
870.2600 Skin Sensitization Negative 
 
Most of the toxicity studies with imazapyr showed no effects to minimal effects, even at 
the HDT (highest dose tested).  There is no evidence of acute or chronic neurotoxicity resulting 
from exposure to imazapyr.  No developmental toxicity was observed in rabbits or rats up to the 
HDT; however, maternal toxicity, based on salivation, was observed in rats at the mid-dose (300 
mg/kg/day).  Neither the rat nor the rabbit study showed an increased susceptibility of the fetus to 
imazapyr administered pre-natally or post-natally.  In addition, a 2-generation reproduction rat 
study did not show increased susceptibility to offspring at doses up to the HDT.  There were no 
compound-related effects in a one-year dietary toxicity study in beagle dogs up to the HDT.  
Imazapyr was classified by the Agency in October 1995 as a “Group E” chemical, with no 
evidence of carcinogenicity in at least 2 adequate studies in the rat and mouse.  This decision was 
reaffirmed on May 22, 2003 by a subcommittee of the Cancer Assessment Review Committee 
(CARC).  Imazapyr is negative for mutagenic potential and a quantitative cancer risk assessment 
is not required.   
 
The Agency selected NOAELs and endpoints for risk assessment purposes in February 
2003.  A 1-year dog feeding study with a NOAEL of 250 mg/kg/day was selected for calculating 
the chronic RfD because it was the lowest NOAEL in the imazapyr database.  Actually, the 250 
mg/kg/day dose in the dog study was both the NOAEL and the highest dose tested for that study. 
Because there were no adverse effects seen in the dog study or in any of the imazapyr toxicity 
studies, EPA relied on a structural analog, the pesticide imazapic (Cadre®), to choose an 
endpoint.  Imazapic causes skeletal muscle effects in dogs at 5000 ppm (137 mg/kg/day in males 
and 180 mg/kg/day in females).   Despite imazapyr’s structural similarity to imazapic, as well as 
its similarity to the pesticides, imazethapyr and imazamethabenz-methyl (Assert®), the available 
data do not support the conclusion that these pesticides share a common mechanism of toxicity 
such that combined exposure to them would result in cumulative effects.  First, as noted, the 
toxicity data for imazapyr show no adverse effects, including no skeletal muscle effects.  Second, 
the toxic endpoints for the three structurally similar pesticides are quite varied:  imazapic (skeletal 
muscle effects); imazethapyr (an increased incidence of clinical signs during gestation, ulcerations 
in the mucosal layer of the stomach and gall bladder, increased abortions, maternal deaths, 
decrements in body weight gain) and imazamethabenz-methyl (transient decreased body weight, 
mild liver effects, slight increase in a common kidney lesion).  Accordingly, for the purposes of 
this RED, EPA has not assumed that imazapyr has a common mechanism of toxicity. 
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Non-cancer risk estimates are expressed as a margin of exposure (MOE) that is a ratio of 
the dose from a toxicological study selected for risk assessment, typically a NOAEL, to the 
predicted exposure.  Estimated MOEs are compared to a level of concern that reflects the dose 
selected for risk assessment and uncertainty factors (UFs) applied to that dose.  The standard UF 
is 100X and includes a 10X for interspecies extrapolation (to account for differences between 
laboratory animals and humans) and a 10X for intraspecies variation (to account for differences 
between humans).  Additional uncertainty or safety factors may also be applied.  In the case of 
imazapyr, the Agency’s level of concern is an MOE of 100 which includes a factor of 10X for 
interspecies extrapolation and 10X for intraspecies variation.  The Special FQPA Safety Factor 
has been reduced to 1X because there are no residual exposure uncertainties, no increased 
sensitivity to infants and children, and the toxicity database is essentially complete.  Table 2 
shows the endpoints selected to assess risks for imazapyr. 
 
Table 2. Summary of Toxicological Doses and Endpoints for Imazapyr Used in the Human 
Health Risk Assessment 
Exposure Scenario Dose Used in Risk Assessment, UF 
Special FQPA SF and 
Level of Concern  
(LOC) for Risk 
Assessment 
Study and Toxicological 
Effects and MRID No. 
Acute Dietary 
(Females 13-50 
years of age and 
General 
population 
including infants 
and children) 
An acute dietary endpoint was not selected based on the absence of an appropriate 
endpoint attributable to a single dose.  
Chronic Dietary 
(All populations) 
NOAEL= 250 
mg/kg/day 
 
UF = 100 
 
Chronic RfD = 
2.5 mg/kg/day 
FQPA SF = 1x 
cPAD = chronic RfD 
               FQPA SF 
= 2.5 mg/kg/day 
1-Year Dog [feeding] Study 
No LOAEL was demonstrated 
with imazapyr at doses up to 
250 mg/kg/day (HDT; MRID 
41039502).  [HIARC assumed 
this dose as an endpoint for RA 
for imazapyr, based on skeletal 
muscle effects seen in dogs 
with structural analog 
imazapic.] 
Short and 
Intermediate 
Term Incidental Oral 
(1-30 days and 1-6 
months) 
NOAEL= 250 
mg/kg/day 
Residential LOC for 
MOE =100) 
1-Year Dog [feeding] Study 
No LOAEL was demonstrated 
with imazapyr at doses up to 
250 mg/kg/day (HDT; MRID 
41039502).  [HIARC assumed 
this dose as an endpoint for RA 
for imazapyr, based on skeletal 
muscle effects seen in dogs 
with structural analog 
imazapic.] 
  
A3-4 
 
Short and 
Intermediate 
and Long-Term 
Dermal (1 to 30 
days, 1 to 6 months, 
>6 months) 
Oral study 
NOAEL= 250 
mg/kg/day  
 
(dermal absorption 
rate = 100 %) 
 
Occupational 
LOC for MOE = 100 
 
(Residential LOC for 
MOE = 100) 
 
1-Year Dog [feeding] Study 
No LOAEL was demonstrated 
with imazapyr at doses up to 
250 mg/kg/day (HDT; MRID 
41039502). [HIARC assumed 
this dose as an endpoint for RA 
for imazapyr, based on skeletal 
muscle effects seen in dogs 
with structural analog 
imazapic.] 
Short- and 
Intermediate and 
Long-Term 
Inhalation (1 to 30 
days, 1 to 6 months, 
>6  months )  
Oral study 
NOAEL= 250 
mg/kg/day 
 
(inhalation absorption 
rate = 100%) 
 
Occupational 
LOC for MOE = 100 
 
(Residential LOC for 
MOE = 100) 
 
1-Year Dog [feeding] Study 
No LOAEL was demonstrated 
with imazapyr at doses up to 
250 mg/kg/day (HDT; MRID 
41039502).  [HIARC assumed 
this dose as an endpoint for RA 
for imazapyr, based on skeletal 
muscle effects seen in dogs 
with structural analog 
imazapic.] 
Cancer  Classified as Group E.  No evidence of carcinogenicity; risk assessment not required.  
UF = uncertainty factor, FQPA SF = Special FQPA safety factor, NOAEL = no observed adverse effect level, LOAEL = lowest 
observed adverse effect level, PAD = population adjusted dose (a = acute, c = chronic),RfD = reference dose, MOE = margin of 
exposure, LOC = level of concern. 
 
Appendix 4 
Selected section on Human Health Risk Assessment related to Aquatic Applications of 
Imazapyr 
From RED (USEPA, 2006): 
 
 Recreational Uses 
 
Imazapyr may be applied by broadcast application to aquatic freshwater sites to control floating 
or emergent aquatic vegetation.  Adults and children may be exposed when swimming in treated 
water bodies following application of imazapyr.  The potential for postapplication incidental 
ingestion and dermal exposure to adults, children, and toddlers as a result of swimming in treated 
waters immediately following application has also been assessed.  Post-application risks to 
adults, children, and toddlers swimming in treated waters following application of imazapyr are 
below the Agency’s level of concern with MOEs ranging from 68,000 to >1,000,000. 
 
Chronic Risk from Food and Drinking Water  
To assess chronic risk from food plus drinking water, exposure estimates from chronic dietary (food) 
and chronic drinking water assessments were combined in the DEEM
TM 
modeling program. The 
modeled EDWC of imazapyr in surface water of 79µg/L was used in the chronic dietary (food plus 
water) assessment. This value was established by modeling imazapyr non-crop uses at the highest 
maximum application. The combined chronic exposure for the general U.S. population and all 
population subgroups is <0.1% of the cPAD. The most highly exposed population subgroup is infants 
<1 year old. The exposure values are below the Agency’s level of concern. 
 
 
Aggregate Risk 
 
Aggregate risk combines exposure from food, drinking water, and, if applicable, residential 
exposure.  For imazapyr, the following aggregate risk assessments were conducted: short-term 
aggregate (food + drinking water + short-term residential) and long-term aggregate risk 
assessment (food + drinking water only).  Based on the current use patterns of imazapyr, the 
Agency does not expect exposure durations that would result in intermediate- or long-term 
residential exposures; therefore long-term aggregate risk assessment consists of exposure from 
food and drinking water only.  A cancer aggregate risk assessment is not required because 
imazapyr is classified as a Group E chemical, “not likely to be carcinogenic”. 
  
 For adult short-term aggregate exposure, the Agency aggregated chronic food and drinking water 
exposures with residential handler and post-application exposures.  The adult residential 
exposure scenarios resulting from application and post-application activities on turf were used.  
For short-term aggregate exposure to children, the Agency aggregated chronic food and drinking 
water exposures for toddlers (1-2 years of age) and combined these with post-application dermal
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and incidental oral exposures (combined hand-to-mouth, object-to-mouth, and soil ingestion) 
from activity on turf.  The estimated MOEs are above 100, with values of 410 for children and 
720 for adults.  Therefore, short-term aggregate risks are below the Agency’s level of concern.   
 
 Because the Agency does not expect chronic residential exposure, long-term aggregate risks are 
equal to chronic dietary risks (food plus water).  As described above in Section 5, these risks are 
below the Agency’s level of concern. 
 
For a complete discussion, see Section 7.0 of the Imazapyr: HED Chapter of the Reregistration 
Eligibility Decision Document, dated December 8, 2005. 
 
6.3.2 Recreational Uses (from HED, USEPA, 2005B) 
Imazapyr may be applied by broadcast application to aquatic freshwater sites to control floating 
or emergent aquatic vegetation.  Adults and children may be exposed should they swim in 
treated water bodies following application of imazapyr.  HED has assessed for 
potentialpostapplication incidental ingestion and dermal exposure to adults and children as a 
result of swimming in treated waters immediately following application.   
The following is excerpted from:  Imazapyr in/on Rangeland and Aquatic Sites. Health Effects 
Division (HED) Risk Assessment.  Dana Vogel. DP Barcode DP291393. July 17, 2003.  
 
A postapplication assessment is included for adults, toddlers, and children swimming in treated 
waters immediately after an application, since the proposed label does not prohibit swimming in 
treated waters. The registrant submitted a field dissipation study using Arsenal
®
 
(MRID:45119707) applied at a rate of 1.6 lb ae/A. At four test sites (Florida and Missouri), the 
highest imazapyr concentration observed was approximately 196 ppb in Missouri; however, at 
the Florida sites, the Environmental Fate and Effects Division (EFED) noted that the initial 
concentrations of imazapyr were only about one-third of the amount applied.  Accounting forthis 
observation, the highest imazapyr concentration could have approached 500 ppb.  Therefore, 
HED estimated a worst-case concentration for imazapyr in the top one-foot of the water column 
in a treated water body; this peak estimate is 550 ppb and is anticipated to be conservative.  
The exposure assumptions used in the swimmer assessment are based on HED’s SOP for 
Residential Exposure Assessments, Draft, December 17, 1997 and HED’s SWIMODEL V 1.0  
(W. Dang and Versar, 27-MAR-1999) for swimming pools adapted for this assessment.  It 
should be noted that the Residential SOP/SWIMODEL assumptions are considered to be 
conservative for use in assessing the lake/pond swimmer scenario as explained in Table 6.3e.  
 
Table 6.3e: Comparison of Assumptions for Postapplication Swimmer Exposure Assessments for 
Imazapyr  
Assumption  Residential SOP for Swimmers 
in Pools  
Arsenal® Application:Postapplication at 
Aquatic Sites  
Postapplication 
concentration  
100% available concentration 
postapplication  
Maximum imazapyr concentration in top one-
foot of water column is approx. 550 ppb. 
Assuming 100% available isconsidered 
conservative.  
Subsequent 
postapplication  Assumed not to dissipate  
Exposed foliage is the intended target of 
treatments.  Any spray entering water column is 
anticipated to dissipate.  
Duration of exposure  5 hours for competitive adult 2 hours for non-competitive child  
2 hours assumed, since floating or emerged 
weeds will be present making competitive 
swimming (training) very difficult  
Inhalation exposure Assumed for pool swimmers 
No significant inhalation exposure is 
anticipated.An inhalation assessment is 
not included. 
 
 
Table 6.3f presents the risk estimates for postapplication exposures by swimmers.  Short-term 
MOEs from dermal and incidental oral exposures to treated lake water (from swimming 
activities) are below HED’s level of concern (i.e., the MOEs are greater than 100).  
Table 6.3f: Postapplication Swimmer Exposure and Risk Assessments for Proposed Use of Imazapyr at 
Aquatic Sites 
 Exposure Scenario  AR (lb ae/A)  
Concentration 
in water (ppb)  
Potential Dose Rate (PDR; 
oral)1 or Absorbed Dose Rate 
(ADR;dermal) 2 (mg/kg/day)  
Short-term 
MOE3  
Incidental Ingestion, adult 
Incidental Ingestion, child 
Incidental Ingestion, 
toddler Dermal, adult  
1.5  550 (0.55 mg/L) 
7.86 x 10-4  320,000  
1.90 x 10-3  130,000  
3.67 x 10-3 68,000  
1.90 x 10-5 > 1 x 107   
Dermal, child  3.24 x 10-5 > 1 x 106  
Dermal, toddler  6.26 x 10-5 > 1 x 106 
 
1. PDR, incidental oral ingestion = concentration, C
w
 (mg/L) x ingestion rate, IgR (L/hr) x exposure time, ET 
(hrs/day) x 1/BW (adult=70 kg; child = 29 kg; toddler = 15 kg)  
2. ADR= concentration, C
w
 (mg/L) x dermal surface area exposed, SA (cm
2
) x ET x K
p
 (cm/hr) x 1/l000 cm
3
 x 
%Dermal Absorption (correct to oral equivalent) x 1/BW, where Kp is estimated as follows: log Kp = -2.72 +0.71log 
ow
 - 0.0061MW; Kow =1.3, MW = 261.3, so Kp = 5.85 x 10
-5
 cm/hr.  
3. MOE = NOAEL/PDR; short-term incidental oral NOAEL = 250 mg/kg/day short-term dermal NOAEL =250 
mg/kg bw/day.  The level of concern for short-term recreational exposures is for MOEs < 100.
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APPENDIX 5 
Estimated Environmental Concentrations (EECs) and Dissipation Behavior of 
Imazapyr following Direct Application to Water  
As part of the ecological risk assessment described in Level I Screening Ecological Risk 
Assessment for the Registration of Imazapyr (USEPA, 2005), the Environmental Fate and Effects 
Division (EFED) of USEPA conducted an exposure assessment to estimate environmental 
concentrations of imazapyr associated with the direct application of imazapyr to surface water. 
The assessment consisted of direct calculation of peak environmental concentrations and 
screening level modeling of estimated exposure concentrations.  
 
Direct Calculation of Peak Concentrations 
 
EFED developed a “standard pond” for aquatic exposure assessments. The “standard pond” has a 
surface area of 1.00 hectares and is 2.00 meters deep and therefore it has a volume of 20,000 
cubic meters or 2.00 x 107 liters (L).   Assuming imazapyr application directly to the entire 
surface of the standard pond, no attenuation by foliar interception and uniform mixing 
throughout its volume, the maximum pond concentration of imazapyr is calculated by dividing 
the total mass of pesticide applied to the pond by its volume at three water depths.  
The maximum imazapyr application rate is 1.50 lb/acre, and since 1.00 lb/acre is equivalent to 
1.121 kg/ha, the application rate is equivalent to 1.682 kg/ha or 1.682 x 109 µg/ha.  Thus, the 
peak concentration for imazapyr is:  
(1.682 x 109 µg/ha x 1.00 ha)/(2.00 x 107 L) = 84.1 µg /L (ppb) 
Direct application of 1.5 pounds of imazapyr to the surface of water bodies 1.0 feet, 3.0 feet and 
3.94 feet deep would produce acute, peak concentrations of 552, 184 and 140 µg/L (ppb), 
respectively.  
 
The 2 meter (6.56 feet) depth is representative of the water depth in the standard pond scenario 
used by EFED for most ecological effects assessments. The 1 and 3 foot water depths are typical 
of use conditions in irrigation and drainage ditches, and for edge of pond depths, where 
problematic aquatic weeds are typically found.  The 3.94 ft depth was included since it is the 
default depth used in the Missouri farm pond model scenario in AQUATOX.  
 
Modeling of Concentration and Dissipation of Imazapyr in Standard Pond 
In order to estimate imazapyr concentrations in the pond as a function of time, used the Generic 
Estimated Environmental Concentration (GENEEC) model as described in Level I screening risk 
assessment (US EPA, 2005). The GENEEC2 model is designed to simulate the ecological 
exposure to aquatic organisms from runoff and spray drift of chemicals applied terrestrially on 
an adjacent field. To assess the exposure for direct application of imazapyr to a water body, 
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EFED had to adjust the GENEEC2 modeling routine and use proportionality factors to yield 
simulated concentrations that matched the directly calculated peak concentration values.   
AQUATOX is an alternative model that is available from USEPA and has the capability to 
estimate the concentration in a water body from direct application of pesticides to a water body. 
AQUATOX is an ecosystem simulation model that predicts the fate of various pollutants, such as 
excess nutrients and organic chemicals, and their effects on aquatic ecosystems. An overview of 
the model is given in Appendix 5. For the purpose of the aquatic exposure assessment for the 
review presented here, the AQUATOX model was used to estimate the concentration and 
dissipation characteristics of imazapyr in a standard pond. The fate portion of the model was 
used to here to characterize the dissipation of imazapyr following an application to a standard 
pond. 
 
Brief overview of the AQUATOX Model 
AQUATOX is an ecosystem simulation model that predicts the fate of various pollutants, such as 
excess nutrients and organic chemicals, and their effects on aquatic ecosystems, including fish, 
invertebrates, and aquatic plants. AQUATOX is a valuable tool for ecologists, biologists, water 
quality modelers, and anyone who performs ecological risk assessments for aquatic ecosystems.  
AQUATOX simulates the transfer of biomass, energy and chemicals from one compartment of 
the ecosystem to another. It does this by simultaneously computing each of the most important 
chemical or biological processes for each day of the simulation period; therefore it is known as a 
process-based or mechanistic model. AQUATOX can predict not only the environmental fate of 
chemicals in aquatic ecosystems, but also their direct and indirect effects on the resident 
organisms. Therefore it has the potential to establish causal links between chemical water quality 
and biological response and aquatic life uses. 
AQUATOX is the only general ecological risk model that represents the combined 
environmental fate and effects of conventional pollutants, such as nutrients and sediments, and 
toxic chemicals in aquatic ecosystems. It considers several trophic levels, including attached and 
planktonic algae and submerged aquatic vegetation, invertebrates, and forage, bottom-feeding, 
and game fish; it also represents associated organic toxicants.  It has been implemented for 
streams, ponds, lakes, estuaries, reservoirs, and experimental enclosures.  
The fate portion of the model, which is applicable especially to organic toxicants, includes: 
partitioning among organisms, suspended and sedimented detritus, suspended and sedimented 
inorganic sediments, and water; volatilization; hydrolysis; photolysis; ionization; and microbial 
degradation. The effects portion of the model includes: acute toxicity to the various organisms 
modeled; and indirect effects such as release of grazing and predation pressure, increase in 
detritus and recycling of nutrients from killed organisms, dissolved oxygen sag due to increased 
decomposition, and loss of food base for animals.   
  
AQUATOX is the latest in a long series of models, starting with the aquatic ecosystem model 
CLEAN (Park et al., 1974) and subsequently improved in consultation with numerous 
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researchers at various European hydrobiological laboratories, resulting in the CLEANER series 
(Park et al., 1975, 1979, 1980; Park, 1978; Scavia and Park, 1976) and LAKETRACE (Collins 
and Park, 1989). The MACROPHYTE model, developed for the U.S. Army Corps of Engineers 
(Collins et al., 1985), provided additional capability for representing submersed aquatic 
vegetation. Another series started with the toxic fate model PEST, developed to complement 
CLEANER (Park et al., 1980, 1982), and continued with the TOXTRACE model (Park, 1984) 
and the spreadsheet equilibrium fugacity PART model. AQUATOX combined algorithms from 
these models with an ecotoxicological construct borrowed from the FGETS model (Suárez and 
Barber, 1992); and additional code was written as required for a truly integrative fate and effects 
model (Park, 1990, 1993).  In the late 1990s, AQUATOX was restructured and linked to 
Microsoft Windows interfaces to provide even greater flexibility, capacity for additional 
compartments, and user friendliness.   
  
• AQUATOX Release 1 was produced in 2002 and was the first EPA release to run under 
Windows.  
• AQUATOX Release 2 was completed in 2003 and included more state variables and 
multi-age-class fish along with a refined user-interface.  
• AQUATOX Release 2.1 was completed in 2005 and included additional chemical 
modeling options and variable stoichiometry among numerous other refinements.  
• AQUATOX Release 2.2 was completed in 2006 and included updated simulations and 
parameter databases along with minor interface enhancements.  
• AQUATOX Release 3 was completed in 2009 and includes linked segments, simulations 
of estuaries, dramatically improved output capabilities, and many other model 
improvements.  
In 2009, EPA released an enhanced version of AQUATOX, Release 3, which includes the 
capability to represent estuaries and to more realistically model nutrients. More information on 
the model and its applications, including references to peer-reviewed publications, is available at 
http://www.epa.gov/waterscience/models/aquatox/. 
 
Model Input 
The model package contains a number of scenarios. The model guidance suggests to select a 
scenario from the model package, and modify it as needed to make it more representative for a 
specific situation and conditions. The model results are suggested to be used for screening-level 
assessments. For the purpose of the review presented here, the model was used to simulate the 
fate of imazapyr in the default Missouri farm pond. The study on esfenvalerate in a Missouri 
Farm Pond was selected as a starting scenario. The state variable defined for this model scenario 
and their initial values are listed in Table A5.1. The site characteristics and chemical parameters 
are shown in attached Table A5-1 and Table A5-2.  
The site characteristic for the latitude was adjusted to 42 in order to make it more representative 
for the light situation in MA. The dimensions of the pond were modified to represent the 
dimensions of the EPA standard pond: Surface area of 1 ha (10000 m2), a depth of 2 m (6.56 ft), 
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and a resulting volume of 20,000 m3. Subsequently, depths of 1.2 m (3.94 ft), 0.91 m (3 ft) and 
0.304 m (1ft) (with associated volumes) of this pond were also simulated.  
Chemical Properties and Fate Data were adjusted to be representative of imazapyr (see Appendix 
2). The following parameter values were used (see also Section 2.4): 
Molecular weight: 261; dissociation constant: 3.8; Henry’s Law constant: 7.1E-17; Octanol-
water partitioning constant (log): 0.22; Water partitioning coefficient: 50; rate of anaerobic 
microbial degradation: 0.00198 (calculated using the half life value of 120 d and k = ln(20/half 
life); Maximum rate of aerobic microbial degradation: 0.00198 (see above); and photolysis rate: 
0.1308 (based on half life of 5.3 d).  
The herbicide application was programmed to occur on May 10th at an amount of 1682 g per day 
(1.5 lbs a.i./acre = 1.682 kg/ha). The model simulation was run from May 1st through August 
31st.  
 
Results 
From the output, the following parameters were selected: dissolved imazapyr concentration, 
imazapyr photolysis, imazapyr biodegradation and total loss of imazapyr. The results are 
presented in graphs that are shown below.  
Note the differences in the concentration scale in the graphs of ponds with different depths. The 
data indicate that photolysis has the largest contribution to the total dissipation of imazapyr. It 
should also be noted that a conservative value for photolysis (longest half life of 5.3 d was used 
in the modeling). Field data may show faster dissipation rates. 
The depth of the pond appears to be an important factor in the dissipation of imazapyr in pond 
water. Application in a shallow pond results in a higher peak concentration (Fig. A5-5). On the 
other hand, more intense light penetration in a shallow pond will result in a higher photolysis rate 
as is indicated in the graph showing the photolysis as a function of pond depth (Fig. A5-6). The 
initial trend of the higher peak concentrations with lower depth is reversed after 2 months when 
the deeper ponds show slightly higher residual concentrations. This may be attributed to the 
lower photolysis rate in deeper ponds.  The concentration trend after 1 month is intermediate to 
the trends observed in initial peak concentration levels and the relatively low levels after 2-
months of dissipation. This may be the result of variation in dissipation due to differences in 
peak concentration and photolysis rate with pond depth. 
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   Figure A5-1 AQUATOX mode-predicted imazapyr concentration  and dissipation in standard pond with 
1 ft depth. 
 
 
    Figure A5-2  AQUATOX model-predicted imazapyr concentration  and dissipation in standard pond 
with 3 ft depth. 
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    Figure A5-3  AQUATOX model-predicted imazapyr concentration  and dissipation in standard pond 
with 3.94 ft depth. 
 
 
 
   Figure A5-4  AQUATOX model-predicted imazapyr concentration  and dissipation in standard pond with 
6.6 ft depth. 
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Figure A5-5  AQUATOX model-predicted imazapyr concentration in standard ponds with different depths. 
 
 
Figure A5-6   AQUATOX model-predicted imazapyr dissipation in standard ponds with different depths. 
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Table A5.1  AQUATOX State Variables for Missouri Farm Pond and their initial values   
State Variable Name  Init. Cond.  Units 
NH3 & NH4+  0.08 mg/L 
NO3  0.05 mg/L 
Tot. Sol. P  0.05 mg/L 
CO2  1.5 mg/L 
Oxygen  12 mg/L 
R detr sed  3 g/m2 dry 
L detr sed  3 g/m2 dry 
R detr diss  0.72 mg/L dry 
L detr diss  0.18 mg/L dry 
R detr part  0.08 mg/L dry 
L detr part  0.02 mg/L dry 
BuryRDetr  2 g/m2 
BuryLDetr  2 g/m2 
Peri High‐Nut Diatom  36.86 g/m2 dry 
Phyt High‐Nut Diatom  0.00 mg/L dry 
Peri, Green  0.01 g/m2 dry 
Phyto, Green  0.00 mg/L dry 
Phyt, Blue‐Greens  0.00 mg/L dry 
Cryptomonas  0.07 mg/L dry 
Myriophyllum  36.67 g/m2 dry 
Chironomid  2.29 g/m2 dry 
Daphnia  0.05 mg/L dry 
Copepod  0.32 mg/L dry 
Sphaerid  2.46 g/m2 dry 
Mayfly (Baetis)  0.24 g/m2 dry 
Rotifer, Keratella  0.07 mg/L dry 
Gastropod  3.68 g/m2 dry 
Shiner  4.02 g/m2 dry 
Largemouth Bass, 
YOY  0.21 g/m2 dry 
Largemouth Bass, Lg  4.43 g/m2 dry 
Water Vol  2004 cu.m 
Temp  16 deg. C 
Wind  0 m/s 
Light  333 Ly/d 
pH  6.8 pH 
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Table A5-2  AQUATOX input values for imazapyr chemical properties and fate data   
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APPENDIX 6.  Ecological Effects Data
Studies are with imazapyr acid, unless otherwise noted
71-1 Avian Acute Oral
Bobwhite Quail. MRID 00131633 (Acceptable).   In a 14-day oral gavage study, imazapyr acid
was determined to be practically non-toxic to bobwhite quail with an LD50 of >2,150 mg ae/kg. 
The study is scientifically sound and follows the guideline protocols. 
Mallard Duck. MRID 00131634 (Acceptable).  In a 14-day oral gavage study, imazapyr acid was
determined to be practically non-toxic to mallard ducks with an LD50 of >2,150 mg ae/kg.  The
study is scientifically sound and follows the guideline protocols. 
71-2 Avian Subacute Dietary  
Imazapyr acid
Bobwhite Quail. MRID 00131635 (Acceptable).  In an 8-day dietary study, imazapyr acid was
determined to be practically non-toxic to upland game birds (bobwhite quail) with an LC50 >5000
ppm.  The study is scientifically sound and generally followed guideline protocols; however, there
was some unexplainable low weight gains and mortality at the 625 ppm test concentration.
Mallard. MRID 00131636 (Acceptable).  In an 8-day dietary study, imazapyr acid was determined
to be practically non-toxic to mallard ducklings with an LC50 >5000 ppm..  The study is
scientifically sound and generally followed guideline protocols.
Imazapyr isopropylamine salt
Bobwhite Quail.  MRID 00147115 (Acceptable).  In an 8-day dietary study, the isopropylamine
salt of imazapyr was determined to be practically non-toxic to upland game birds (bobwhite quail)
with an LC50 >5000 ppm.  The study is scientifically sound and generally followed guideline
protocols.  This study was conducted with the formulated product to ensure that isopropylamine
did not affect the toxicity of the active ingredient.
71-4 Avian Reproduction
Bobwhite Quail.  MRID 45119714a (Acceptable).  In a one-generation reproductive toxicity
study, imazapyr acid produced no evidence of treatment-related adverse effects on adult or
reproductive parameters with an NOAEC of 1670 ppm.  The study is scientifically sound and
generally followed guideline protocols.
Mallard.  MRID 45119714b (Invalid).  In a one-generation reproductive toxicity study, imazapyr
acid resulted in a significant reduction in the ratio of viable embryos/eggs at the 1,670 ppm
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treatment level.  However, the study was determined to be invalid due to bacterial contamination
and high embryonic mortality in the controls.  EFED recommended that another study be
conducted to determine the reproductive toxicity of imazapyr to waterfowl. 
Bobwhite Quail.  MRID 43831401 (Originally Supplemental; Reclassified Core).  In a one-
generation reproductive toxicity study, imazapyr acid resulted in reduced hatchlings/live embryo
at 2000 ppm (LOEC; NOEC = 1000 ppm); however, the study was originally determined to be
supplemental due to guideline deficiencies (primarily, EECs would be higher than highest dose
tested and control egg shell cracking was 13%).  EFED reevaluated the studies and determined
that the dosing did reflect the maximum EEC and that the handling and measurement deficiencies
did not reflect a dose-response relationship; consequently, the study was reclassified as core and
the NOEC was changed to 2000 ppm.
Mallard.  MRID 43831402 (Originally Supplemental; Reclassified Core).  In a one-generation
reproductive toxicity study, imazapyr acid produced no evidence of treatment-related adverse
effects on adult or reproductive parameters with an NOAEC of 1890 ppm (measured
concentration; 2000 ppm nominal concentration).   However, the study was originally determined
to be supplemental due to guideline deficiencies (primarily, EECs would be higher than highest
dose tested, inaccurate measurement of egg shell thickness, and insufficient pre-egg laying period. 
EFED reevaluated the studies and determined that the dosing did reflect the maximum EEC and
that the measurement deficiencies did not reflect a dose-response relationship; consequently, the
study was reclassified as core and the NOAEC was established at 2000 ppm. 
72-1 Freshwater Fish Acute
Imazapyr acid
Rainbow Trout. MRID 00131629 (Acceptable).  In a 96-hour acute test,  imazapyr acid was
determined to be practically non-toxic to rainbow trout with an LC50 of  >100 mg/L.  The NOEC
was determined to be 100 mg/L.  The study is scientifically sound and meets guideline protocols.
Bluegill Sunfish. MRID 00131630 (Acceptable). In a 96-hour acute test, imazapyr acid was
determined to be practically non-toxic to bluegill sunfish with an LC50 of  >100 mg/L.  The NOEC
was determined to be 100 mg/L.  The study is scientifically sound and meets guideline protocols.
Channel Catfish. MRID 00131631(Acceptable). In a 96-hour acute test, imazapyr acid was
determined to be practically non-toxic to channel catfish with an LC50 of  >100 mg/L.  The NOEC
was determined to be 100 mg/L.  The study is scientifically sound and meets guideline protocols.
Imazapyr isopropylamine salt
Rainbow Trout. MRID 45119713 (Acceptable).  In a 96-hour flow-through test, imazapyr
isopropylamine salt was determined to be practically non-toxic to rainbow trout with an LC50 of 
>110 mg ae/L (mean measured concentration; nominal concentration 120 mg ae/L).  The NOEC
was determined to be 110 mg ae/L.  The study is scientifically sound and meets guideline
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    protocols.
Bluegill Sunfish. MRID 00147116 (Acceptable). In a 96-hour test, imazapyr isopropylamine salt
was determined to be practically non-toxic to bluegill sunfish with an LC50 of  >818 mg ae/L
(1000 mg ai/L).  The study is scientifically sound and meets guideline protocols.
72-2 Freshwater Invertebrate Acute
Imazapyr acid
Daphnia. MRID 00131632 (Core).  In a 48-hour acute test, imazapyr acid was determined to be
practically non-toxic to daphnids with an EC50 of >100 mg/L.  The study is scientifically sound
and meets guideline protocols.
Imazapyr isopropylamine salt
Daphnia. MRID 00147117 (Core).  In a 48-hour static test, imazapyr isopropylamine salt was
determined to be practically non-toxic to daphnids with an EC50 of 614 mg ae/L (750 mg ai/L). 
The study is scientifically sound and meets guideline protocols.
72-3a Estuarine/Marine Fish Acute
Silverside Minnow. MRID 41315801(Acceptable). In a 96-hour flow-through test, imazapyr acid
was determined to be practically non-toxic to silverside minnow with an LC50 of  >184 mg ai/L
(mean measured concentration; nominal concentration 200 mg ai/L).  The NOEC was determined
to be 184 mg ai/L.  The study is scientifically sound and meets guideline protocols.
72-3b Estuarine/Marine Invertebrate Acute
Eastern Oyster. MRID 45119710 (Acceptable).  In a 96-hour flow-through test, imazapyr acid
was determined to be practically non-toxic to the eastern oyster with an EC50 of  >132 mg ai/L
(mean measured concentration; nominal concentration 120 mg ai/L).  No mortalities were
observed in either the treated or control groups.  The control shell deposition during the study
was 2.46 mm.  The NOAEC was determined to be 132 mg ai/L, the highest concentration tested.  
No significant adverse effects were observed on shell deposition for any treated group.  The study
is scientifically sound and meets guideline protocols.
Eastern Oyster.  MRID 41315802 (Supplemental).  In a 96-hour flow-through test, imazapyr acid
was determined to be practically non-toxic to the eastern oyster with an EC50 of  >173 mg ai/L
(mean measured concentration; nominal concentration 200 mg ai/L; the highest concentration
tested).  No mortalities were observed in either the treated or control groups.  There was a
statistically significant decrease in mean shell deposition at 173 mg/L when compared to the
control group (p # 0.05).  The NOAEC was determined to be 109 mg ai/L.  Originally, this study
was classified as invalid because the control oyster growth (1.35 mm new shell deposition) did not
meet the guideline requirement of 2 mm (amendment to SEP, dated 9/1990).  In addition, the
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flow rate of the test solution was 1.05 L/oyster/hour.  The protocols recommended by the SEP
(APHA, 1981 and EPA, 1976) state that each oyster should receive a minimum of 5
L/oyster/hour.  This study was later upgraded to supplemental.  The memorandum stated that
shell growth in the control group may be used as an indicator of stress for the oysters.  Less than
2 mm shell growth in the control group indicates that the oysters may be undergoing stress.  The
low flow-through rate with no supplemental food added in this study may have contributed to
stress on the oysters.  For this study, it appears that the seawater was trucked in from the ocean
to Gainesville, Florida.  During such time, the food organisms (such as algae) may have been
inhibited during the transport and storage.  The oysters in the study may not have fed well
because of the combination of the lower amount of available food organisms in the shipped sea
water, the low flow rate and the lack of supplemental food added; thereby, contributing to
inadequate shell deposition.  However, since there was some dose-response, the study was
upgraded to supplemental.
Pink Shrimp.  MRID 41315803 (Acceptable).   In a 96-hour flow-through test, imazapyr acid was
determined to be practically non-toxic to pink shrimp with an LC50 of  >189 mg ai/L (mean
measured concentration; nominal concentration 200 mg ai/L).  There was one mortality at the
second highest concentration level (111 mg/L), which does not appear to be related to treatment.
No other signs of toxicity were observed.  Therefore, the NOAEC was determined to be 189 mg
ai/L, the highest concentration tested.  The study is scientifically sound and meets guideline
protocols.
72-4a Freshwater Fish Early Life Stage
Fathead Minnow. MRID 45119711 (Acceptable).  In an early life-stage flow-through test,
imazapyr acid produced no treatment-related effects on embryonic survival, time to hatch, alevin
survival, terminal length, or wet and dry weight.  The NOEC was determined to be 118 mg ai/L
(mean measured concentration; nominal concentration 120 mg ai/L).  The study is scientifically
sound and meets guideline protocols.
Rainbow Trout.  MRID 41315804 (Supplemental).  In an early life-stage flow-through test,
imazapyr acid resulted in significantly reduced percent hatch and an observed reduction on
survival at 92.4 mg/L (mean measured concentration; nominal concentration 100 mg/L).  No
abnormalities in embryonic or juvenile development were observed.  The MATC was >43.1 and
<92.4 mg/L; thus the geometric mean MATC was 63.1 mg/L.  The study did not meet all
guideline requirements (feeding limited the growth of replicates with higher fish densities).
72-4b Freshwater Invertebrate Life Cycle
Daphnia.  MRID 41315805 (Acceptable).  In a life cycle flow-through test, imazapyr acid
produced no treatment-related effects on survival, growth and reproduction of first generation
daphnids.  No physical or behavioral abnormalities were observed.  The MATC and NOEL were
determined to be $97.1 mg/L.  The study is scientifically sound and meets guideline protocols.
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   72-5 Freshwater Fish Life Cycle
Fathead Minnow. MRID 45119712 (Supplemental).  In a full life cycle flow-through test,
imazapyr acid produced no treatment-related effects on growth, embryo survival, time to hatch,
or larval and juvenile survival of the F0 and F1 generations.  No treatment-related effects were
observed on percent spawning frequency, mean number of eggs produced per female or mean
percent fertilization success.  The NOEC was reported at the nominal concentration of 120 mg
ai/L (mean measured concentration 118 mg ai/L).  The study is scientifically valid but did not
meet all guideline requirements (F1 generation was maintained for 4 weeks instead of 8 weeks).
81-1 Acute Mammalian Oral
Imazapyr acid
Rat. MRID 132030 (Acceptable).  In an acute oral study, imazapyr acid was determined to have a
low toxicity (Toxicity Category III) to rats with an LD50 >5000 mg/kg.  The study is scientifically
sound and meets guideline protocols.
Imazapyr isopropylamine salt
Rat. MRID 00147049 (Acceptable).  In an acute oral study, imazapyr isopropylamine salt was
determined to exhibit no toxicity (Toxicity Category IV) to rats with an LD50 of  >5000 mg/kg
(>4090 mg ae/kg).  The study is scientifically sound and meets guideline protocols.
Rat. MRID 44735301 (Acceptable).  In an acute oral study, imazapyr isopropylamine salt was
determined to exhibit no toxicity (Toxicity Category IV) to rats with an LD50 of  >5000 mg/kg
(>4090 mg ae/kg).  The study is scientifically sound and meets guideline protocols.
83-3 Mammalian Developmental
Rat. MRID 00131611 (Acceptable).  In a 2-generation developmental study, imazapyr acid
produced maternal toxicity in Sprague Dawley rats at 1000 mg ai/kg/day (LOAEL), based on
salivation in the gravid dams between gestation days 8-15.  The findings were determined to be
treatment-related.  The NOAEL was 300 mg /kg bw/day.  No treatment-related effects were
reported for developmental parameters.  The study is scientifically sound and meets guideline
protocols.
Rabbit. MRID 00131613 (Acceptable).  In a 2-generation teratology study, imazapyr acid
produced no treatment-related effects for maternal or developmental parameters; consequently,
the NOAEL for both endpoints was $400 mg/kg bw/day in New Zealand white rabbits.  The
study is scientifically sound and meets guideline protocols.
83-4 Mammalian Reproduction
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Rat. MRID 41039505 (Acceptable).  In a 2-generation reproduction study, imazapyr acid
produced no treatment-related effects for maternal or developmental parameters; consequently,
the parental systemic, reproductive, and offspring NOAEL was $738 mg/kg bw/day in males and
933.3 mg/kg bw/day in females.  The study is scientifically sound and meets guideline protocols.
122-2 Aquatic Plant Nonvascular
Imazapyr acid
Green algae. MRID 40811802 (Acceptable). In a Tier II toxicity test with Selenastrum
capricornutum, the 7 day EC50 for cell density was 71 mg ai/L (NOEC = 50.9 mg ai/L).  The
study is scientifically sound and meets the guideline protocols.
Blue-green algae. MRID 40811802 (Acceptable). In a Tier II toxicity test with Anabaena flos-
aquae, the7-day EC50 for cell density was 12.2 mg ai/L (NOEC = 9.6 mg ai/L).  The study is
scientifically sound and meets the guideline protocols.
Marine diatom. MRID 40811802 (Acceptable). In a Tier II toxicity test with Skeletonema
costatum, the7-day EC50 for cell density was 92 mg ai/L (NOEC = 15.9 mg ai/L).  The study is
scientifically sound and meets the guideline protocols.
Diatom. MRID 40811802 (Acceptable). In a Tier II toxicity test with Navicula pelliculosa, the 7-
day EC50 for cell density was >41 mg ai/L (NOEC = 41 mg ai/L).  The study is scientifically
sound and meets the guideline protocols.
Imazapyr isopropylamine salt
Green algae. MRID 43889102 (Acceptable). In a Tier II toxicity test with green algae, the 7-day
EC50, based on slight changes in cell shape was 11.5 mg ae/L (NOEC = 7.16 mg ae/L).  The study
is scientifically sound and meets the guideline protocols.
123-1(a) Seedling Emergence - Tier II
Imazapyr Acid
Monocots (4 species) and Dicots (4 species).  MRID 40811801 (Supplemental).  In a Tier II
seedling emergence study, the most sensitive monocot tested was wheat (EC25 0.0046 lb ae/acre,
EC05 0.00099 lb ae/acre; shoot weight).  The most sensitive dicot tested was sugarbeet (EC25
0.0024 lb ae/acre,  EC05 0.00017 lb ae/acre; shoot weight). Due to deficiencies in the study, the
guideline requirements are only partially fulfilled; acceptable data endpoints were used in the risk
assessment.
Nontarget Terrestrial Plant Seedling Emergence Toxicity (Tier II)
Species % ai EC25 (lbs ai/A) NOEC / [EC05] Endpoint Affected MRID No. Study Classification
22.6% 408118-01
Monocot- Corn 0.025 0.0156 height invalid2
Nontarget Terrestrial Plant Seedling Emergence Toxicity (Tier II)
Species % ai EC25 (lbs ai/A) NOEC / [EC05] Endpoint Affected MRID No. Study ClassificationA
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Monocot- Oat 0.054 0.0156 “ supplemental3
Monocot- Onion 0.034 [0.01]A weight4 supplemental3
Monocot- Wheat 0.0046 [0.00099]A “ supplemental3
Dicot- Sunflower 0.0027 [0.000021]A height invalid2
Dicot- Soybean 0.012 0.0078 “ invalid2
Dicot- Pea 0.093 0.0624 weight4 invalid2
Dicot-Cucumber 0.0043 [0.000005]A “ invalid2
Dicot- Sugarbeet 0.0024 [0.00017]A “ supplemental3
Dicot- Tomato 0.008 0.0003 “ supplemental3
 
1Determination of the most sensitive species is based on EC25 values; results are based on the non-linear regression
analysis. 
2
 Large seedlings were subjected to overcrowding, 10 seeds were planted in a 4-in dixie cup.
3
 Small seedlings could be subjected to overcrowding, 10 seeds were planted in a 4-in dixie cup.
4
 Fresh weight was recorded instead of dry weight. 
A
 The NOEC value is above the EC25, equal to the EC25, or below the lowest concentration, an EC05 value is used
instead. .  
123-1(b) Vegetative Vigor - Tier II
Imazapyr acid
Monocots (4 species) and Dicots (4 species).  MRID 40811801 (Supplemental).  In a Tier II
vegetative vigor study, the most sensitive monocot tested was wheat (EC25 0.012 lb ae/acre,
NOEC 0.0039 lb ae/acre; shoot weight).  The most sensitive dicot tested was cucumber (EC25
0.0009 lb ae/acre,  EC05 0.000064 lb ae/acre; shoot height).  Due to deficiencies in the study, the
guideline requirements are partially fulfilled; acceptable data endpoints were used in the risk
assessment.  
Species
% a.i. EC25 
(lbs ae/A)
NOEC [EC05]
(lbs ae/A)
Endpoint affected MRID No. Study
classification
22.6% 408118-01
Monocot-Corn >0.0156A 0.0078 weight2 supplemental3
Monocot-Oats 0.013 0.0039 height supplemental3
Monocot-Onion -- -- n/aC invalid
Monocot-Wheat 0.012 0.0039 weight2 supplemental3
Dicot-Soybean -- -- n/aC invalid
Dicot-Pea -- -- n/aC invalid
Dicot-Sugarbeet 0.00097 [0.00039]B weight2 supplemental3
Species
% a.i. EC25 
(lbs ae/A)
NOEC [EC05]
(lbs ae/A)
Endpoint affected MRID No. Study
classificationA
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Dicot-Sunflower 0.0054 0.0039 weight2 supplemental3
Dicot-Cucumber 0.0009 [0.000064]B height supplemental3
Dicot-Tomato >0.0156A 0.00097 weight2 supplemental3
1Determination of the most sensitive species is based on EC25 values.
2  
 Fresh weight was recorded instead of dry weight. 
3
 the toxicity values could be underestimated since the study was tested with older plants (28D) at a less sensitive
stage of growth (timing of application).
A The EC25 value is above the highest concentration tested.
B
 The NOEC value is above the EC25, equal to the EC25, or below the lowest concentration, an EC05 value is used
instead. 
C
 No data
Imazapyr isopropylamine salt
Monocots (3 species) and Dicots (2 species).  MRID 43889101 (Core).  In a Tier II vegetative
vigor study, chlorosis, stunting, and plant death.  The most sensitive monocot tested was onion
(EC25 0.010 lb ae/acre, NOEC 0.004 lb ae/acre; shoot weight).  The most sensitive dicot tested
was sugar beet (EC25 0.0016 lb ae/acre, NOEC 0.0008 lb ae/acre; shoot weight). The study is
scientifically sound and meets guideline protocols.
Monocots (4 species) and Dicots (4 species).  MRID 40003711 (Supplemental).  This study was a
modified Tier II vegetative vigor study that did not meet guideline requirements.  Only descriptive
summary data was presented; consequently effect levels were not determined.  Observed effects
included chlorosis, stunting, leaf tip burning, necrosis, and plant death. 
123-2 Aquatic Plant Vascular
Imazapyr acid
Duckweed. MRID 40811802 (Acceptable).  In a 14-day toxicity test with duckweed, the EC50 for
frond production was 0.024 mg ai/L and the NOEC was 0.01 mg ai/L.  Imazapyr is considered
highly toxic and expected to exert a detrimental effect on vascular aquatic plants.  The study is
scientifically sound and meets guideline protocols.
Imazapyr isopropylamine salt
Duckweed. MRID 43889102 (Acceptable).  In a 14-day toxicity test with duckweed, the EC50 for
frond production was 0.018 mg ai/L and the NOEC was 0.011 mg ai/L.  The study is scientifically
sound and meets guideline protocols.
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Appendix 7 
 
Selected Information on Ecological Risk Characterization (From Level I, USEPA, 2005A): 
 
A. Summary Tables 
Table A7-1. Summary of Environmental Risk Conclusions for Aquatic Animals and Plants.  
Assessment 
Endpoint  
Use Patterns with LOC 
Exceedances  
Summarized Risk Characterization1  
Acute Risk to 
Freshwater Fish and 
Amphibians 1 
None  LC50 values all greater than highest concentration tested. 
RQs not estimated; however, if highest concentration 
tested were used to calculate RQs, acute LOCs would 
not be exceeded for any uses.  
Chronic Risk to 
Freshwater Fish and 
Amphibians 1 
None  Chronic LOC not exceeded for any uses.  
Acute Risk to 
Freshwater 
Invertebrates  
None  LC50 values all greater than highest concentration tested. 
RQs not estimated; however, if highest concentration 
tested were used to calculate RQs, acute LOCs would 
not be exceeded for any uses.  
Chronic Risk to 
Freshwater 
Invertebrates  
None  Chronic LOC not exceeded for any uses.  
Acute Risk to 
Estuarine/Marine Fish  
None  LC50 values all greater than highest concentration tested. 
RQs not estimated; however, if highest concentration 
tested were used to calculate RQs, acute LOCs would 
not be exceeded for any uses.  
1  Fresh water fish are surrogate for aquatic-phase amphibians 
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Table A7-2. Summary of Environmental Risk Conclusions for Aquatic Animals and Plants.  
Assessment 
Endpoint  
Use Patterns with LOC 
Exceedances  Summarized Risk Characterization
1 
Chronic Risk to 
Estuarine/Marine Fish  
No data available  Estimated chronic effects for estuarine/marine fish 
uncertain because no chronic data were submitted by 
the registrant; in estimating risk, an assumption was 
made that marine/estuarine fish would be of similar 
sensitivity as the freshwater fish.  
Acute Risk to 
Estuarine/Marine 
Invertebrates  
None  LC50 values all greater than highest concentration 
tested. RQs not estimated; however, if highest 
concentration tested were used to calculate RQs, 
acute LOCs would not be exceeded for any uses.  
Chronic Risk to 
Estuarine/Marine 
Invertebrates  
No data available  Estimated chronic effects for estuarine/marine 
invertebrates uncertain because no chronic data were 
submitted by the registrant; in estimating risk, an 
assumption was made that marine/estuarine 
invertebrates would be of similar sensitivity as the 
freshwater invertebrates.  
Risk to Aquatic Plants  Terrestrial Noncrop Uses 
(1.5 lb ae/acre) Terrestrial 
Noncrop Uses (0.9 lb 
ae/acre) Terrestrial Noncrop 
Granular Uses (0.5 lb 
ae/acre) Aquatic Noncrop 
Uses (1.5 lb ae/acre)  
Endangered and non-endangered LOCs are exceeded 
for aquatic vascular plants from high application 
rate. No LOCs were exceeded for aquatic non-
vascular plants. Endangered and non-endangered 
LOCs are exceeded for aquatic vascular plants from 
low application rate. No LOCs were exceeded for 
aquatic non-vascular plants. Endangered and non-
endangered LOCs are exceeded for aquatic vascular 
plants from low application rate. No LOCs were 
exceeded for aquatic non-vascular plants. 
Endangered and non-endangered LOCs are exceeded 
for aquatic vascular plants from high application 
rate. No LOCs were exceeded for aquatic non-
vascular plants.  
1 includes granular, ground and aerial applications unless specified.  
 
 
Table A7-3. Summary of Environmental Risk Conclusions for Terrestrial Animals and Plants.  
Risk Conclusion  Use Patterns with LOC 
Exceedances  
Summarized Risk Characterization  
Acute Risk to Birds 
(and reptiles)  
None  LC50/LD50 values all greater than highest 
concentration tested. RQs not estimated.  Acute risk 
to birds is low because highest estimated EECs are 
one quarter (broadcast spray) to one-half (granular 
application) of highest concentration tested in acute 
studies which produced no mortalities and no clinical 
signs of toxicity.  
Chronic Risk to Birds 
(and reptiles)  
None  Chronic LOC not exceeded for any uses.  
Acute Risk to 
Mammals  
None  LC50 values all greater than highest concentration 
tested. RQs not estimated.  Acute risk to mammals is 
low because highest estimated EECs are 1/32 
(broadcast spray) to less than 1/10 (granular 
application) of highest concentration tested in acute 
studies which produced no mortalities and no clinical 
signs of toxicity.  
Chronic Risk to 
Mammals  
None  Chronic LOC not exceeded for any uses.  
Risk to Non-target 
Invertebrates  
None likely  Low toxicity to bees.  Qualitative assessment 
indicates probable low risk.  
 
 
 
Table IB-2. Summary of Environmental Risk Conclusions for Terrestrial Animals and Plants.  
Risk Conclusion  Use Patterns with LOC 
Exceedances  
Summarized Risk Characterization  
Risk to Terrestrial 
Plants  
Terrestrial Noncrop Uses 
(1.5 lb ae/acre)  
 
 
 
 
 
 
Terrestrial Noncrop Uses 
(0.9 lb ae/acre)  
 
 
 
 
 
 
 
 
 
 
Terrestrial Noncrop 
Granular Uses  
(0.5 lb ae/acre)  
 
 
 
 
 
 
 
Clearfield corn  
(0.014 lbs ae/acre)  
 
 
 
 
 
 
 
Aquatic Noncrop Uses 
 (1.5 lb ae/acre)  
Endangered and non-endangered LOCs are exceeded 
for terrestrial monocots and dicots in dry and semi-
aquatic areas receiving a combination of runoff and 
drift and from spray drift alone from high application 
rate via ground and aerial applications and exceeded 
for plants in areas receiving runoff via granular 
application.  
 
Endangered and non-endangered LOCs are exceeded 
for terrestrial monocots and dicots in dry and semi-
aquatic areas receiving a combination of runoff and 
drift and from spray drift alone from low application 
rate via ground and aerial applications. However, the 
non-endangered LOC is not exceeded for monocots 
receiving spray drift alone via ground applications. 
Endangered and non-endangered LOCs are exceeded 
for terrestrial monocots and dicots in dry and semi-
aquatic areas receiving runoff from low application rate 
via granular broadcast application.  
 
Endangered and non-endangered LOCs are exceeded 
for terrestrial monocots and dicots in semi-aquatic 
areas receiving a combination of runoff and drift via 
ground and aerial applications for corn use. The 
endangered LOC is exceeded for dicots in dry areas 
receiving a combination of runoff and drift and from 
spray drift alone via ground and aerial applications, and 
exceeded for monocots in dry areas receiving a 
combination of runoff and drift via aerial application.  
 
Endangered LOCs were not exceeded for monocots in 
dry areas receiving a combination of runoff and drift 
via ground application and from spray drift alone via 
ground and aerial applications. The non-endangered 
LOC was not exceeded for monocots and dicots in dry 
areas receiving a combination of runoff and drift and 
from spray drift alone via ground and aerial 
applications.  
 
Endangered and non-endangered LOCs are exceeded 
for terrestrial monocots and dicots adjacent to or on the 
edge of a water body receiving a combination of runoff 
and drift and from spray drift alone via ground and 
aerial applications.  
 
 
 
 
 
B. Risk Description  
1. Risks to Aquatic Organisms  
In the conceptual model, direct application, spray drift and surface runoff/leaching to adjacent 
bodies of water were predicted as the most likely sources of exposure of imazapyr and the 
isopropylamine salt of imazapyr to nontarget aquatic organisms.  Risks to aquatic organisms (i.e. 
fish, invertebrates, and plants) were assessed based on modeled estimated environmental 
concentrations (EECs) and available toxicity data. Aquatic EECs for the ecological exposure to 
imazapyr were estimated using GENEEC2 employing the standard field pond scenario (Table 
IIIB-2).  
The risk hypothesis stated that the use of imazapyr has the potential to cause adverse effects to 
both terrestrial and aquatic animals and plants.  The assessment refutes this hypothesis regarding 
animals in that direct effects to terrestrial and aquatic animals are unlikely.  The hypothesis is 
confirmed for terrestrial and aquatic plants, and, through possible indirect effects, for adverse 
effects to nontarget terrestrial and aquatic animals.  
a. Animals  
Fish and Invertebrates  
Available acute toxicity data for aquatic species indicate that imazapyr acid is practically non-
toxic to fish and invertebrates with LC
50
 and EC
50
 values >100 mg/L. The only sublethal effect 
observed in the acute aquatic animal studies is a decrease in shell deposition in the eastern 
oyster. The NOAEC/LOAEC for this effect was 109/173 mg/L.  In order to compare these 
values with an exposure value, the highest peak EEC in surface water was selected from the 
aquatic uses, which utilize direct application to water. The EEC estimation assumes a 1-foot 
water depth. A comparison of the ecotoxicity values listed above (between 100000 - 173000 
ppb) with the peak EEC in surface water (552 ppb), indicates a 181 to 313-fold difference 
between the highest estimated EEC and the concentrations which produced either no effects 
(100000 - 109000 ppb) or a decreased shell deposition in oysters (173000 ppb). The estimated 
peak EEC in surface water from the granular uses is less than 552 ppb.  Therefore, it is 
concluded that the acute risk to fish and aquatic invertebrates is expected to be very low.  
Following chronic exposure, the NOAEC/LOAEC for freshwater fish is 43.1/92.4 mg/L and the 
NOAEC for freshwater invertebrates is 97.1 mg/L, the highest concentration tested.  Chronic risk 
quotients are all < 0.002 for all scenarios except for the aquatic uses. For aquatic uses (direct 
application to water, assuming 1 foot water depth), the highest chronic EECs are 549 ppb (21 
day) and 542 ppb (60 day). Using the NOAEC of 43.1 mg/L (43100 ppb) for freshwater fish and 
the 60-day EEC, the estimated RQ would be 0.013.  All other scenarios (Table III B-3) would 
have RQs <0.013 because the EECs are significantly lower than 549 ppb and 542 ppb.  
Consequently, the risks for acute and chronic adverse effects related to reproduction, growth, and 
survival are low for fish and invertebrates inhabiting surface waters adjacent to an imazapyr 
treated field. The assumption of minimal risk for marine/estuarine fish and invertebrates
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following chronic exposure is based on an assumption of equal sensitivity to their freshwater 
counterparts. However, if estuarine/marine fish and invertebrates studies are submitted and are 
more sensitive to potential adverse chronic effects of imazapyr, then risks may be underestimated 
for these taxonomic groups.    
An in situ microcosm study found no effects following a single application of imazapyr up to a 
concentration of 19.8 mg/L on the macroinvertebrate community of a logged pond cypress dome. 
Comparing this NOAEC (19800 ppb) with the peak EEC in surface water (552 ppb) indicates a 
36-fold difference. Although the data from this study are limited because examinations were 
conducted at the family/genus level and effects on individual species were not examined , it does 
support the laboratory studies on aquatic invertebrates. When taken together, all the studies 
combined indicate that the risk to benthic organisms is not likely.   
b. Aquatic Plants  
Toxicity studies indicate that imazapyr acid is highly toxic and expected to exert detrimental 
effects to aquatic vascular plants. The imazapyr acid EC
50
 for the freshwater vascular plant 
(duckweed) is 0.024 mg/L (NOAEC 0.01 mg/L), based on inhibition of plant growth and 
reduction of frond count. The toxicity of the isopropylamine salt of imazapyr to duckweed is 
similar to the acid, with a 14-day EC
50
 of 0.018 mg ae/L (NOAEC = 0.011 mg ae/L).  Studies 
with non-vascular aquatic plants (algae and diatoms) indicate that imazapyr acid and its salt are 
not expected to exert detrimental effects to non-vascular plants, at the maximum application 
rate when compared to the LOCs for non-listed and listed species.  Risk to non-vascular plants 
is then compared to the listed species LOC for any potential indirect effects to listed plant and 
animal species.  
For the use scenarios modeled (Table II.e.) for imazapyr, there were no LOC exceedances for 
listed and non-listed aquatic non-vascular plants (Tables IVA-5 and IVA-6) from direct effects. 
However, the LOCs for non-endangered and endangered aquatic vascular plants were exceeded 
for the terrestrial non-cropped spray and granular uses (at high and low application rates) and for 
the aquatic non-cropped uses, at application rates of 1.5 lb ae/acre. For the Clearfield corn use, 
LOCs were not exceeded for non-endangered and endangered aquatic vascular plants. 
Consequently, aquatic vascular plants inhabiting surface waters adjacent to a treated field, and 
those exposed via direct application to water, would be at risk for adverse effects to growth and 
development as a result of the labeled uses of the pesticide.  The potential risk to endangered 
aquatic vascular plants will be discussed in greater detail in Section IV.B.4.  
 
2. Risks to Terrestrial Organisms  
In the conceptual model, direct application, ground deposition, spray drift, root uptake, and wind 
erosion of soil particles with resulting residues on foliage and on flowers and seeds are the most 
likely sources of imazapyr exposure to nontarget terrestrial organisms, including listed species.  
Risks to terrestrial organisms (i.e. birds, mammals, and plants) were assessed based on modeled 
EECs and available toxicity data.
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a. Animals  
Birds  
Acute risk quotients were not estimated for birds because there was no mortality nor any other 
signs of toxicity in either the acute oral studies or the acute dietary studies.  For terrestrial non-
crop uses with spray applications of 1.5 lb ae/acre, the highest EEC concentration for birds is 
410 mg/kg bw for short grass consumed by a 20 g bird.  The adjusted LD
50
 for 20 g birds would 
be > 1549 mg/kg bw.  There is an approximately four-fold difference between these two values. 
Since there were neither mortalities nor clinical signs of toxicity at 1549 mg/kg bw, the acute 
risk to birds following spray applications is likely to be low.  
Following granular applications, the highest LD
50
/square foot is > 0.5 for 20 g birds. This means 
that the estimated EEC is approximately one-half of the highest concentration tested in the acute 
study which produced no mortalities and no clinical signs of toxicity.  Therefore, again, the acute 
risk to birds following a broadcast granular application is also likely to be low.  
The chronic LOC for birds is not exceeded for any of the registered uses.  
Mammals  
As with birds, risk quotients were not estimated for mammals because there was no mortality or 
clinical signs of toxicity observed in the acute oral study.  For terrestrial noncrop uses with spray 
applications, the highest EEC concentration for mammals is 343 mg/kg bw for short grass 
consumed by a 15 g mammal.  The adjusted LD
50
 for 15 g mammals would be >10989 mg/kg bw. 
There is an approximately 32-fold difference between these two values.  Since there were neither 
mortalities nor clinical signs of toxicity at 10989 mg/kg bw, the acute risk to mammals following 
spray applications is likely to be low.  
Following granular applications, the highest LD
50
/square foot is 0.09 for 15 g mammals. 
Therefore, the estimated EEC is less than one-tenth of the highest concentration tested in the 
acute study, which produced no mortalities and no clinical signs of toxicity.  The acute risk to 
mammals following a broadcast granular application is also likely to be low.  
The chronic LOC for mammals is not exceeded for any of the registered uses.  
Terrestrial Non-target Insects  
The available terrestrial insect toxicity data, based on tests with honey bees, suggests that 
imazapyr is practically non-toxic to bees.  Tests with honey bees provide an acute LD
50
 > 100 
µg/bee. Risk to terrestrial insects in the direct treatment area is expected to be low.  
b. Terrestrial Plants  
Based on the toxicity data presented in Ecological Effects Section , the results indicate that for 
the non-crop terrestrial uses at both the high and low application rates by ground and aerial 
spray, the Non-Endangered Species LOC (with the exception of monocots at the low rate as a
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result of spray drift alone from ground application) and the Endangered Species LOC were 
exceeded for monocots and dicots located adjacent to treated areas, inhabiting semi-aquatic 
areas, and as a result of a combination of runoff and spray drift and spray drift alone.   
 
4. Endocrine Effects  
Imazapyr and its isopropylamine salt have shown no indication of inducing endocrine-
related effects following exposure.  
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